The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up‐to‐date guidance for the management of HAE. For this update and revi...
Uloženo v:
| Vydáno v: | Allergy (Copenhagen) Ročník 77; číslo 7; s. 1961 - 1990 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Denmark
Blackwell Publishing Ltd
01.07.2022
Wiley |
| Témata: | |
| ISSN: | 0105-4538, 1398-9995, 1398-9995 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up‐to‐date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on‐demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast‐feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients. |
|---|---|
| AbstractList | Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up‐to‐date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on‐demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast‐feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients. Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast-feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast-feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients. Abstract Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up‐to‐date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on‐demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast‐feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients. |
| Author | Kaplan, Allen Phillip Magerl, Markus Castaldo, Anthony Gompels, Mark Boysen, Henrik Balle Hide, Michihiro Craig, Timothy Busse, Paula J. Boccon‐Gibod, Isabelle Bygum, Anette Guidos‐Fogelbach, Guillermo Farkas, Henriette Kiani‐Alikhan, Sorena Prior, Nieves Varga, Lilian Agnes Toubi, Elias Spaeth, Peter J. Stobiecki, Marcin Lockey, Richard Rafique Sheikh, Farrukh Bara, Noémi‐Anna Caballero, Teresa Aberer, Werner Martinez Saguer, Inmaculada Grumach, Anete S. Betschel, Stephen Matta, Juan José Maurer, Marcus Riedl, Marc Weller, Karsten Kang, Hye‐Ryun Smith, William B. Pawankar, Ruby Katelaris, Constance Gower, Richard Bork, Konrad Ritchie, Bruce Cohn, Danny M. Reshef, Avner Aygören‐Pürsün, Emel Csuka, Dorottya Longhurst, Hilary Nast, Alexander Peter, Jonathan Zanichelli, Andrea Nieto‐Martinez, Sandra A. Brodszki, Nicholas Lumry, William R. Zuraw, Bruce Porebski, Grzegorz Ansotegui, Ignacio J. Lei, Wei‐Te Nguyen, Dinh Cancian, Mauro Malbran, Alejandro Banerji, Aleena Bouillet, Laurence MacGinnitie, Andrew Zhi, Yuxiang |
| Author_xml | – sequence: 1 givenname: Marcus orcidid: 0000-0002-4121-481X surname: Maurer fullname: Maurer, Marcus email: marcus.maurer@charite.de organization: Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology – sequence: 2 givenname: Markus orcidid: 0000-0001-9218-5468 surname: Magerl fullname: Magerl, Markus email: markus.magerl@charite.de organization: Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology – sequence: 3 givenname: Stephen surname: Betschel fullname: Betschel, Stephen organization: University of Toronto – sequence: 4 givenname: Werner surname: Aberer fullname: Aberer, Werner organization: Medical University of Graz – sequence: 5 givenname: Ignacio J. surname: Ansotegui fullname: Ansotegui, Ignacio J. organization: Hospital Quironsalud Bizkaia – sequence: 6 givenname: Emel surname: Aygören‐Pürsün fullname: Aygören‐Pürsün, Emel organization: University Hospital Frankfurt – sequence: 7 givenname: Aleena surname: Banerji fullname: Banerji, Aleena organization: Massachusetts General Hospital – sequence: 8 givenname: Noémi‐Anna surname: Bara fullname: Bara, Noémi‐Anna organization: Mediquest Clinical Research Center – sequence: 9 givenname: Isabelle surname: Boccon‐Gibod fullname: Boccon‐Gibod, Isabelle organization: Grenoble Alpes University Hospital – sequence: 10 givenname: Konrad orcidid: 0000-0002-6084-4577 surname: Bork fullname: Bork, Konrad organization: Johannes Gutenberg University – sequence: 11 givenname: Laurence orcidid: 0000-0001-8245-4767 surname: Bouillet fullname: Bouillet, Laurence organization: Grenoble Alpes University Hospital – sequence: 12 givenname: Henrik Balle surname: Boysen fullname: Boysen, Henrik Balle organization: HAE International (HAEi) – sequence: 13 givenname: Nicholas surname: Brodszki fullname: Brodszki, Nicholas organization: Skåne University Hospital – sequence: 14 givenname: Paula J. surname: Busse fullname: Busse, Paula J. organization: Icahn School of Medicine at Mount Sinai – sequence: 15 givenname: Anette surname: Bygum fullname: Bygum, Anette organization: Odense University Hospital – sequence: 16 givenname: Teresa orcidid: 0000-0003-3005-9858 surname: Caballero fullname: Caballero, Teresa organization: IdiPaz, CIBERER U754 – sequence: 17 givenname: Mauro surname: Cancian fullname: Cancian, Mauro organization: University Hospital of Padua – sequence: 18 givenname: Anthony surname: Castaldo fullname: Castaldo, Anthony organization: HAE International (HAEi) – sequence: 19 givenname: Danny M. surname: Cohn fullname: Cohn, Danny M. organization: Amsterdam UMC/University of Amsterdam – sequence: 20 givenname: Dorottya orcidid: 0000-0003-3610-9852 surname: Csuka fullname: Csuka, Dorottya organization: Semmelweis University – sequence: 21 givenname: Henriette orcidid: 0000-0003-2929-1721 surname: Farkas fullname: Farkas, Henriette organization: Semmelweis University – sequence: 22 givenname: Mark surname: Gompels fullname: Gompels, Mark organization: North Bristol NHS Trust – sequence: 23 givenname: Richard surname: Gower fullname: Gower, Richard organization: Principle Research Solutions – sequence: 24 givenname: Anete S. surname: Grumach fullname: Grumach, Anete S. organization: Centro Universitario FMABC – sequence: 25 givenname: Guillermo surname: Guidos‐Fogelbach fullname: Guidos‐Fogelbach, Guillermo organization: Instituto Politécnico Nacional SEPI‐ENMH – sequence: 26 givenname: Michihiro surname: Hide fullname: Hide, Michihiro organization: Hiroshima University – sequence: 27 givenname: Hye‐Ryun orcidid: 0000-0002-2317-4201 surname: Kang fullname: Kang, Hye‐Ryun organization: Seoul National University College of Medicine – sequence: 28 givenname: Allen Phillip orcidid: 0000-0002-6566-4743 surname: Kaplan fullname: Kaplan, Allen Phillip organization: Medical university of South Carolina – sequence: 29 givenname: Constance surname: Katelaris fullname: Katelaris, Constance organization: Campbelltown Hospital and Western Sydney University – sequence: 30 givenname: Sorena surname: Kiani‐Alikhan fullname: Kiani‐Alikhan, Sorena organization: Barts Health NHS Trust – sequence: 31 givenname: Wei‐Te orcidid: 0000-0003-1677-8901 surname: Lei fullname: Lei, Wei‐Te organization: Mackay Memorial Hospital – sequence: 32 givenname: Richard surname: Lockey fullname: Lockey, Richard organization: University of South Florida – sequence: 33 givenname: Hilary surname: Longhurst fullname: Longhurst, Hilary organization: University of Auckland – sequence: 34 givenname: William R. surname: Lumry fullname: Lumry, William R. organization: University of Texas Health Science Center – sequence: 35 givenname: Andrew orcidid: 0000-0002-9451-3733 surname: MacGinnitie fullname: MacGinnitie, Andrew organization: Harvard Medical School – sequence: 36 givenname: Alejandro surname: Malbran fullname: Malbran, Alejandro organization: Unidad de Alergia, Asma e Inmunología Clínica – sequence: 37 givenname: Inmaculada surname: Martinez Saguer fullname: Martinez Saguer, Inmaculada organization: Haemophilia Centre Rhine Main (HZRM) – sequence: 38 givenname: Juan José surname: Matta fullname: Matta, Juan José organization: H. Especialidades C.M.N.SXXI, I.M.S.S – sequence: 39 givenname: Alexander orcidid: 0000-0003-3504-2203 surname: Nast fullname: Nast, Alexander organization: Humboldt University of Berlin, and Berlin Institute of Health – sequence: 40 givenname: Dinh surname: Nguyen fullname: Nguyen, Dinh organization: VinUniversity – sequence: 41 givenname: Sandra A. surname: Nieto‐Martinez fullname: Nieto‐Martinez, Sandra A. organization: National Institute of Pediatrics – sequence: 42 givenname: Ruby orcidid: 0000-0002-3091-7237 surname: Pawankar fullname: Pawankar, Ruby organization: Nippon Medical School – sequence: 43 givenname: Jonathan orcidid: 0000-0002-2658-0723 surname: Peter fullname: Peter, Jonathan organization: University of Cape Town Lung Institute – sequence: 44 givenname: Grzegorz orcidid: 0000-0002-6146-0188 surname: Porebski fullname: Porebski, Grzegorz organization: Jagiellonian University Medical College – sequence: 45 givenname: Nieves surname: Prior fullname: Prior, Nieves organization: Hospital Universitario Severo Ochoa – sequence: 46 givenname: Avner orcidid: 0000-0002-3324-7072 surname: Reshef fullname: Reshef, Avner organization: Barzilai University Medical Center – sequence: 47 givenname: Marc surname: Riedl fullname: Riedl, Marc organization: University of California San Diego – sequence: 48 givenname: Bruce surname: Ritchie fullname: Ritchie, Bruce organization: University of Alberta – sequence: 49 givenname: Farrukh surname: Rafique Sheikh fullname: Rafique Sheikh, Farrukh organization: King Faisal Specialist Hospital & Research Centre – sequence: 50 givenname: William B. surname: Smith fullname: Smith, William B. organization: Royal Adelaide Hospital – sequence: 51 givenname: Peter J. surname: Spaeth fullname: Spaeth, Peter J. organization: University of Bern – sequence: 52 givenname: Marcin surname: Stobiecki fullname: Stobiecki, Marcin organization: Jagiellonian University Medical College – sequence: 53 givenname: Elias surname: Toubi fullname: Toubi, Elias organization: Technion‐Israel Institute of Technology – sequence: 54 givenname: Lilian Agnes orcidid: 0000-0002-5484-364X surname: Varga fullname: Varga, Lilian Agnes organization: Semmelweis University – sequence: 55 givenname: Karsten orcidid: 0000-0003-4437-0313 surname: Weller fullname: Weller, Karsten organization: Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology – sequence: 56 givenname: Andrea surname: Zanichelli fullname: Zanichelli, Andrea organization: Ospedale Luigi Sacco‐University of Milan – sequence: 57 givenname: Yuxiang orcidid: 0000-0001-7539-6650 surname: Zhi fullname: Zhi, Yuxiang organization: Bejing Union Medical College Hospital & Chinese Academy of Medical Sciences – sequence: 58 givenname: Bruce surname: Zuraw fullname: Zuraw, Bruce organization: University of California, San Diego – sequence: 59 givenname: Timothy surname: Craig fullname: Craig, Timothy organization: Penn State University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35006617$$D View this record in MEDLINE/PubMed https://hal.science/hal-04997520$$DView record in HAL |
| BookMark | eNp9kcFq3DAURUVJaSZpF_2BIuimXTjzJFm2tDRD0gQM2aR0KWT7eUZBtqeynZBdP6Jf2C-J3ElTCLTaPJDOvXrce0KO-qFHQt4zOGPxrK33Z0xylr4iKya0SrTW8oisgIFMUinUMTkZx1sAyLmGN-RYSIAsY_mK7G92SF0_Yejt5IbeevqtuF6fF8Xmim5n16B3PdJ2CHSKZGd7u8UO-4kOLd1hwMZNNjxQ22_dgA129tePn4snB85owDs3Rtf43NB539gJ35LXrfUjvnuap-TrxfnN5jIpr79cbYoyqVPO06QCkSlogFcZWlYDMCWwEqrVmKOFTCiJXNYCpNZ5VemUC1CNzYXVStRxnpLPB9-d9WYfXBe3NIN15rIozXIHaVRKDncssp8O7D4M32ccJ9O5sUbvbY_DPBqeMSVBpJpH9OML9HaYY3Z-oRRnChhLI_XhiZqrDpvn___k_ne7OgzjGLB9RhiYpVMTOzW_O43s-gVbx8yXsqZgnf-f4t55fPi3tSnK8qB4BBcqr2U |
| CitedBy_id | crossref_primary_10_2500_aap_2024_45_240034 crossref_primary_10_1016_j_reval_2025_104583 crossref_primary_10_3390_ijms241512184 crossref_primary_10_1007_s12016_024_09006_1 crossref_primary_10_1111_pai_13825 crossref_primary_10_1111_all_15618 crossref_primary_10_1016_j_revmed_2023_01_020 crossref_primary_10_3389_fimmu_2024_1324671 crossref_primary_10_1016_j_jacig_2023_100179 crossref_primary_10_1016_j_jacig_2023_100178 crossref_primary_10_1002_clt2_12391 crossref_primary_10_2500_aap_2025_46_250017 crossref_primary_10_3389_fphar_2025_1550133 crossref_primary_10_1016_j_anai_2024_12_012 crossref_primary_10_1111_1346_8138_17912 crossref_primary_10_1016_j_jaip_2022_07_035 crossref_primary_10_1056_NEJMoa2402478 crossref_primary_10_2500_aap_2024_45_240046 crossref_primary_10_3389_fimmu_2024_1400526 crossref_primary_10_3389_fimmu_2025_1631448 crossref_primary_10_1016_j_anai_2025_02_003 crossref_primary_10_1111_all_15861 crossref_primary_10_1007_s12325_025_03226_3 crossref_primary_10_1016_j_ienj_2023_101339 crossref_primary_10_1016_S0140_6736_23_00438_5 crossref_primary_10_1056_NEJMcps2307935 crossref_primary_10_1093_cei_uxae020 crossref_primary_10_1186_s12903_025_06359_7 crossref_primary_10_1016_j_jaip_2022_11_006 crossref_primary_10_3389_fped_2024_1408110 crossref_primary_10_1016_j_jaip_2023_05_031 crossref_primary_10_1111_1346_8138_16713 crossref_primary_10_1056_NEJMoa2405734 crossref_primary_10_33590_emjallergyimmunol_PNMJ4065 crossref_primary_10_1007_s12026_024_09547_9 crossref_primary_10_57264_cer_2024_0205 crossref_primary_10_3389_fimmu_2025_1550380 crossref_primary_10_1016_j_waojou_2025_101083 crossref_primary_10_1186_s13223_023_00795_2 crossref_primary_10_1177_01455613241284900 crossref_primary_10_3389_fimmu_2024_1399459 crossref_primary_10_1007_s40629_022_00223_8 crossref_primary_10_1055_a_1874_6835 crossref_primary_10_1016_j_anai_2024_01_027 crossref_primary_10_1001_jama_2025_11165 crossref_primary_10_21518_ms2025_191 crossref_primary_10_1016_j_jaip_2025_05_045 crossref_primary_10_2500_aap_2024_45_240021 crossref_primary_10_33590_emj_VBKS3456 crossref_primary_10_3238_arztebl_m2025_0122 crossref_primary_10_1016_j_jaci_2025_08_005 crossref_primary_10_1371_journal_pone_0311316 crossref_primary_10_1056_NEJMoa2309149 crossref_primary_10_1007_s15012_024_8542_1 crossref_primary_10_2340_actadv_v104_24176 crossref_primary_10_1016_j_jaip_2022_12_021 crossref_primary_10_1111_1346_8138_16817 crossref_primary_10_2500_aap_2025_46_250027 crossref_primary_10_2500_aap_2025_46_250026 crossref_primary_10_1016_j_ajoms_2024_03_005 crossref_primary_10_1093_cei_uxae121 crossref_primary_10_1016_j_anai_2023_06_014 crossref_primary_10_2500_aap_2025_46_250029 crossref_primary_10_1016_j_jacig_2023_100087 crossref_primary_10_2500_aap_2025_46_250028 crossref_primary_10_1111_1346_8138_17106 crossref_primary_10_1016_S0140_6736_22_02406_0 crossref_primary_10_1016_j_iac_2022_05_011 crossref_primary_10_1016_j_coi_2025_102653 crossref_primary_10_3389_fgene_2022_914376 crossref_primary_10_1016_j_anai_2023_11_016 crossref_primary_10_1016_j_jaip_2023_12_019 crossref_primary_10_1177_09733698241255547 crossref_primary_10_3390_sports13070215 crossref_primary_10_1016_j_waojou_2025_101060 crossref_primary_10_1016_j_jaip_2023_06_022 crossref_primary_10_1177_11206721241228003 crossref_primary_10_1007_s43678_024_00834_w crossref_primary_10_1016_j_anai_2025_03_016 crossref_primary_10_1016_j_waojou_2024_100882 crossref_primary_10_1080_14712598_2025_2512128 crossref_primary_10_1111_pai_70133 crossref_primary_10_1111_1346_8138_16909 crossref_primary_10_1186_s13023_025_03739_8 crossref_primary_10_1016_j_gene_2024_148496 crossref_primary_10_7759_cureus_56449 crossref_primary_10_1016_j_waojou_2024_100885 crossref_primary_10_1016_j_jacig_2025_100414 crossref_primary_10_1111_cea_14182 crossref_primary_10_1111_all_16197 crossref_primary_10_1016_j_jaci_2024_03_024 crossref_primary_10_1093_ced_llad428 crossref_primary_10_15557_PiMR_2023_0053 crossref_primary_10_15557_PiMR_2023_0054 crossref_primary_10_3389_fimmu_2024_1472390 crossref_primary_10_7759_cureus_32075 crossref_primary_10_1002_psp4_70009 crossref_primary_10_1053_j_gastro_2024_01_032 crossref_primary_10_7759_cureus_91346 crossref_primary_10_1016_j_jaip_2023_12_025 crossref_primary_10_1097_ACI_0000000000000995 crossref_primary_10_1111_joim_20008 crossref_primary_10_18553_jmcp_2025_31_6_578 crossref_primary_10_4103_ara_ara_4_24 crossref_primary_10_1080_20469047_2024_2317488 crossref_primary_10_1097_ACI_0000000000000992 crossref_primary_10_1097_ACI_0000000000001047 crossref_primary_10_1016_j_jaci_2024_03_028 crossref_primary_10_1155_2024_3028617 crossref_primary_10_1097_ACI_0000000000001042 crossref_primary_10_1016_j_anai_2024_07_018 crossref_primary_10_1111_1346_8138_17421 crossref_primary_10_1111_ddg_15154 crossref_primary_10_1136_ejhpharm_2023_004046 crossref_primary_10_1007_s10049_024_01415_1 crossref_primary_10_1016_j_redar_2025_501732 crossref_primary_10_1111_all_15437 crossref_primary_10_1111_ddg_15154_g crossref_primary_10_1111_all_16643 crossref_primary_10_33590_emjallergyimmunol_PRFG1459 crossref_primary_10_3390_life13041021 crossref_primary_10_57264_cer_2022_0188 crossref_primary_10_7759_cureus_47644 crossref_primary_10_2500_aap_2022_43_220069 crossref_primary_10_1186_s13023_025_03776_3 crossref_primary_10_1016_j_jaip_2025_01_021 crossref_primary_10_3389_fmed_2024_1343547 crossref_primary_10_1016_S0140_6736_23_00267_2 crossref_primary_10_57264_cer_2024_0110 crossref_primary_10_1111_all_16099 crossref_primary_10_1186_s13223_024_00934_3 crossref_primary_10_2147_JAA_S396338 crossref_primary_10_57264_cer_2024_0237 crossref_primary_10_5415_apallergy_0000000000000102 crossref_primary_10_1002_clt2_70026 crossref_primary_10_1016_j_jaci_2022_11_027 crossref_primary_10_1080_14728214_2022_2105834 crossref_primary_10_5415_apallergy_0000000000000100 crossref_primary_10_1016_j_anpedi_2022_11_007 crossref_primary_10_1016_j_jacig_2023_100166 crossref_primary_10_3390_ijms231810332 crossref_primary_10_1016_j_ajem_2025_04_059 crossref_primary_10_1007_s15007_022_5601_y crossref_primary_10_36290_med_2025_048 crossref_primary_10_1089_ped_2023_0083 crossref_primary_10_3389_fimmu_2025_1502325 crossref_primary_10_1111_cea_70014 crossref_primary_10_3389_fimmu_2024_1442671 crossref_primary_10_33393_ao_2025_3468 crossref_primary_10_1016_j_clim_2025_110542 crossref_primary_10_29262_ram_v71i4_1323 crossref_primary_10_3390_jcm13020477 crossref_primary_10_1002_clt2_12300 crossref_primary_10_1016_j_asjsur_2025_07_310 crossref_primary_10_1016_j_jaci_2024_12_1079 crossref_primary_10_3389_fimmu_2025_1576235 crossref_primary_10_3390_children11020237 crossref_primary_10_3389_fimmu_2024_1413547 crossref_primary_10_3389_fmed_2022_930403 crossref_primary_10_2302_kjm_2023_0008_IR crossref_primary_10_1080_14740338_2023_2177269 crossref_primary_10_1089_bfm_2023_0157 crossref_primary_10_2500_aap_2024_45_230073 crossref_primary_10_1136_bcr_2024_263566 crossref_primary_10_1016_j_jaip_2023_07_036 crossref_primary_10_1186_s13223_025_00955_6 crossref_primary_10_3389_falgy_2025_1636425 crossref_primary_10_3389_fimmu_2024_1339421 crossref_primary_10_2500_aap_2024_45_230080 crossref_primary_10_1007_s40801_025_00505_x crossref_primary_10_1016_j_jaut_2024_103216 crossref_primary_10_1089_derm_2023_0309 crossref_primary_10_1186_s13023_024_03251_5 crossref_primary_10_1007_s12016_023_08972_2 crossref_primary_10_1016_j_waojou_2022_100694 crossref_primary_10_1016_j_jaip_2025_07_029 crossref_primary_10_1007_s10875_023_01565_w crossref_primary_10_1186_s42269_023_01147_1 crossref_primary_10_1016_j_redare_2025_501732 crossref_primary_10_1016_j_waojou_2023_100833 crossref_primary_10_1016_j_jaip_2024_05_047 crossref_primary_10_1111_all_16563 crossref_primary_10_1007_s40801_024_00470_x crossref_primary_10_1097_01_NURSE_0000891944_11247_83 crossref_primary_10_3390_metabo12111140 crossref_primary_10_3390_ijms25031804 crossref_primary_10_21802_e_GMJ2025_A24 crossref_primary_10_1016_j_anai_2025_07_012 crossref_primary_10_1016_j_fander_2025_03_016 crossref_primary_10_1002_jvc2_103 crossref_primary_10_1007_s10875_025_01912_z crossref_primary_10_1186_s13023_024_03247_1 crossref_primary_10_1111_jocd_15438 crossref_primary_10_36290_vnl_2023_050 crossref_primary_10_1002_jvc2_582 crossref_primary_10_1016_j_vesic_2024_100056 crossref_primary_10_1186_s13223_024_00903_w crossref_primary_10_1016_j_jaip_2024_04_007 crossref_primary_10_4081_itjm_2024_1836 crossref_primary_10_3390_ph17030360 crossref_primary_10_1111_1346_8138_16883 crossref_primary_10_1186_s13223_022_00689_9 crossref_primary_10_1016_j_jaip_2023_03_032 crossref_primary_10_3389_falgy_2025_1565283 crossref_primary_10_3390_healthcare11182509 crossref_primary_10_2147_JAA_S445893 crossref_primary_10_1080_13543784_2024_2320700 crossref_primary_10_3389_fmed_2025_1483405 crossref_primary_10_1080_03009742_2023_2230737 crossref_primary_10_3390_jcm14051659 crossref_primary_10_1002_clt2_12313 crossref_primary_10_1007_s00508_023_02298_x crossref_primary_10_1080_14656566_2025_2482737 crossref_primary_10_1111_cea_14632 crossref_primary_10_1016_j_waojou_2025_101100 crossref_primary_10_33590_emj_10307646 crossref_primary_10_1136_bmj_2022_074239 crossref_primary_10_3390_jcm12237299 crossref_primary_10_1016_j_jacig_2025_100446 crossref_primary_10_1016_j_jaip_2024_09_016 crossref_primary_10_1016_S2352_3026_24_00081_4 crossref_primary_10_1111_ddg_15889 crossref_primary_10_1186_s13223_025_00969_0 crossref_primary_10_3389_froh_2023_1257703 crossref_primary_10_1002_clt2_70076 crossref_primary_10_1016_j_mcna_2023_05_018 crossref_primary_10_33590_emjallergyimmunol_IAHX5562 crossref_primary_10_3389_fneur_2025_1555562 crossref_primary_10_1097_MCG_0000000000001744 crossref_primary_10_1016_j_jaip_2023_09_009 crossref_primary_10_1111_1346_8138_17838 crossref_primary_10_1080_14656566_2025_2509782 crossref_primary_10_1186_s13023_024_03182_1 crossref_primary_10_1515_cclm_2024_0024 crossref_primary_10_1056_NEJMoa2109329 crossref_primary_10_1016_j_jaip_2023_09_003 crossref_primary_10_1093_mrcr_rxaf022 crossref_primary_10_1186_s13023_025_03988_7 crossref_primary_10_1111_all_16351 crossref_primary_10_1016_j_anai_2022_11_007 crossref_primary_10_1111_pai_14268 crossref_primary_10_1186_s13023_025_03562_1 crossref_primary_10_1016_j_anai_2025_07_025 crossref_primary_10_1186_s41687_025_00876_3 crossref_primary_10_3389_falgy_2025_1554940 crossref_primary_10_1016_j_jaip_2024_06_041 crossref_primary_10_1016_j_jaip_2023_04_035 crossref_primary_10_1016_j_jaip_2024_12_008 crossref_primary_10_1056_NEJMoa2314192 crossref_primary_10_2500_aap_2025_46_240096 crossref_primary_10_1002_jcph_6162 crossref_primary_10_1007_s40521_022_00326_1 crossref_primary_10_1186_s12967_024_05216_5 crossref_primary_10_1002_clt2_12342 crossref_primary_10_1016_j_anai_2024_08_001 crossref_primary_10_1016_j_iac_2024_03_009 crossref_primary_10_1186_s13023_025_03882_2 crossref_primary_10_1002_eji_70010 crossref_primary_10_3390_medicina60111777 crossref_primary_10_1016_j_anai_2023_03_005 crossref_primary_10_1016_j_waojou_2023_100758 crossref_primary_10_1159_000541242 crossref_primary_10_3389_falgy_2025_1604440 crossref_primary_10_1055_s_0042_1758820 crossref_primary_10_1007_s12016_025_09027_4 crossref_primary_10_1080_14712598_2024_2441845 crossref_primary_10_1093_cei_uxad091 crossref_primary_10_33590_emjallergyimmunol_IEYW6199 crossref_primary_10_5415_apallergy_0000000000000172 crossref_primary_10_1111_cea_14568 crossref_primary_10_1016_j_waojou_2023_100784 crossref_primary_10_1016_S0140_6736_23_00350_1 crossref_primary_10_1111_pai_70072 crossref_primary_10_1186_s13223_025_00947_6 crossref_primary_10_1111_1346_8138_16965 crossref_primary_10_1080_14740338_2023_2226861 crossref_primary_10_3390_jcm14041375 crossref_primary_10_3389_fped_2023_1141073 crossref_primary_10_1016_j_anai_2024_11_029 crossref_primary_10_1016_j_anai_2025_06_004 crossref_primary_10_1016_j_anpede_2023_04_008 crossref_primary_10_2147_TCRM_S310376 crossref_primary_10_25259_IJDVL_1002_2023 crossref_primary_10_3389_jcia_2024_12626 crossref_primary_10_1007_s00134_024_07611_4 crossref_primary_10_1016_j_jaip_2023_04_017 crossref_primary_10_1016_j_jaip_2023_10_017 crossref_primary_10_3390_biom14101298 crossref_primary_10_1016_j_jaip_2024_12_027 crossref_primary_10_1093_skinhd_vzaf055 crossref_primary_10_1016_j_jaci_2023_09_039 crossref_primary_10_1016_j_jaip_2024_12_023 crossref_primary_10_1213_XAA_0000000000001833 crossref_primary_10_1186_s13023_024_03302_x crossref_primary_10_1016_j_anai_2023_03_028 crossref_primary_10_1186_s13223_023_00861_9 |
| Cites_doi | 10.1001/jama.2018.16773 10.1111/j.1398-9995.2011.02751.x 10.1056/NEJM199606203342503 10.2500/ar.2017.8.0210 10.1111/j.1365-2133.2009.09366.x 10.1016/j.jbiotec.2012.09.005 10.1111/j.1572-0241.2006.00492.x 10.1016/0090-1229(72)90006-2 10.1056/NEJMoa1605767 10.1016/j.waojou.2019.100049 10.1016/j.jaci.2011.11.025 10.1111/j.1398-9995.2010.02433.x 10.1016/j.jaci.2012.12.789 10.1111/all.13397 10.1016/j.iac.2017.04.007 10.1016/j.clim.2011.11.005 10.1016/0091-6749(81)90181-0 10.1016/j.aller.2012.01.002 10.1155/2019/9157895 10.1186/s13023-019-1043-3 10.1016/j.jaip.2021.03.057 10.1055/s-0038-1647471 10.1186/s13023-020-1334-8 10.5152/tao.2020.5994 10.1016/j.jaci.2009.07.017 10.1016/j.molimm.2019.06.017 10.1177/0091217419837068 10.2500/aap.2020.41.200050 10.2500/aap.2015.36.3820 10.1016/j.amjmed.2005.09.064 10.1159/000351236 10.1016/j.jaip.2013.07.002 10.1016/j.iac.2013.07.003 10.1111/pai.12364 10.2500/aap.2020.41.200042 10.1111/j.1398-9995.2010.02530.x 10.1002/humu.23917 10.1016/j.jaip.2021.04.072 10.1007/s00105-018-4318-z 10.1016/j.biologicals.2006.08.005 10.1157/13106781 10.1159/000439032 10.1080/17512433.2016.1182425 10.1007/BF00168965 10.1016/j.jaci.2020.10.015 10.1056/NEJM197301042880123 10.1186/s13223-019-0328-3 10.1111/cea.12055 10.2500/aap.2015.36.3831 10.26442/00403660.2020.12.200447 10.2340/00015555-2233 10.1111/all.12007 10.1007/s12016-021-08839-4 10.1186/s13023-014-0205-6 10.1016/j.jaip.2016.04.018 10.2500/aap.2021.42.210066 10.1007/s00228-009-0771-z 10.1016/j.anai.2013.12.004 10.1007/s00431-012-1726-4 10.1111/j.1610-0387.2010.07546_suppl.x 10.1016/j.jaip.2016.12.032 10.1007/BF00164878 10.3390/jcm9113402 10.1136/jcp.2003.12021 10.1111/bcp.12132 10.1016/j.jaci.2012.08.036 10.1016/j.jaci.2014.02.036 10.1056/NEJMoa1716995 10.31744/einstein_journal/2021RW5498 10.1111/all.13384 10.1016/j.anai.2016.03.008 10.1186/s13256-020-02622-3 10.1097/MD.0000000000004363 10.5604/01.3001.0014.0619 10.1016/S1081-1206(10)60369-9 10.1111/j.0954-6820.1972.tb04818.x 10.1016/0049-3848(81)90206-1 10.1016/S0140-6736(00)02483-1 10.1111/all.15011 10.1016/j.jaip.2020.08.046 10.2500/aap.2020.41.190021 10.1016/S0168-8278(02)00035-1 10.1111/all.13466 10.2500/aap.2010.31.3403 10.1111/j.1523-5378.2007.00501.x 10.1016/j.clinthera.2010.04.017 10.2500/aap.2015.36.3824 10.3389/fmed.2017.00245 10.1186/s13223-017-0203-z 10.7326/0003-4819-86-3-306 10.2147/IJWH.S46460 10.1016/S1081-1206(10)60584-4 10.1111/j.1399-3038.2005.00275.x 10.1186/s13023-018-0815-5 10.1016/j.ajog.2010.03.003 10.2500/aap.2021.42.210006 10.1016/S0140-6736(99)00110-5 10.18176/jiaci.0102 10.1016/j.jaip.2019.08.011 10.1111/pai.12495 10.2500/ajra.2011.25.3661 10.1016/j.anai.2012.12.007 10.2500/aap.2013.34.3702 10.1016/j.iac.2013.07.005 10.1016/j.jaci.2004.06.043 10.1016/j.iac.2013.07.001 10.1007/s12016-021-08854-5 10.1016/j.revmed.2020.06.010 10.18176/jiaci.0037 10.1111/all.14680 10.1016/j.jpeds.2012.11.030 10.1034/j.1399-3038.2002.01014.x 10.1016/j.jaci.2010.07.021 10.2500/aap.2014.35.3753 10.1111/all.12731 10.1111/cei.12083 10.1203/00006450-199402000-00012 10.1136/adc.49.8.636 10.1016/j.jpba.2020.113844 10.1111/all.14416 10.1080/17512433.2020.1776110 10.1016/j.anai.2010.04.012 10.1016/j.jim.2008.06.004 10.1016/j.ajog.2008.04.034 10.1542/peds.2006-3303 10.2500/aap.2017.38.4038 10.14219/jada.archive.2003.0323 10.1186/1749-8090-5-86 10.1111/all.12032 10.1177/0897190019857407 10.1007/s10875-010-9442-1 10.1186/s12948-021-00141-0 10.1111/all.12680 10.1007/s00011-013-0693-1 10.1111/j.1537-2995.2009.02394.x 10.2500/aap.2019.40.4213 10.1016/j.anai.2010.06.005 10.1016/j.jaip.2020.08.052 10.1111/all.12186 10.1186/s13023-020-01570-x 10.1007/s00063-018-0483-1 10.1016/j.anai.2014.05.009 10.2500/aap.2013.34.3645 10.1016/j.ejogrb.2010.05.008 10.1016/j.jaad.2004.09.032 10.4065/75.4.349 10.1016/S0140-6736(97)09137-X 10.1111/j.1742-1241.2005.00352.x 10.1186/s13023-021-01717-4 10.1016/j.jaip.2018.04.022 10.1007/s12016-018-8684-1 10.1371/journal.pone.0053773 10.1046/j.1537-2995.1998.38698326333.x 10.1111/all.14144 10.1016/j.anai.2015.01.003 10.1016/j.jaip.2013.09.008 10.1111/joim.13182 10.3389/fmed.2017.00212 10.1016/j.anai.2016.10.006 10.1007/s10875-015-0222-9 10.1016/0091-6749(80)90181-5 10.2500/aap.2017.38.4087 10.1186/s13023-020-01658-4 10.1007/s12016-021-08837-6 10.2217/imt.15.44 10.1016/j.jaip.2014.09.001 10.1097/PEC.0000000000002402 10.1177/0009922815616886 10.1016/j.lpm.2015.01.005 10.1016/j.anai.2015.04.005 10.1089/bfm.2014.0027 10.1016/j.anai.2019.02.019 10.1186/s13023-017-0604-6 10.1016/j.lpm.2014.06.030 10.1159/000430864 10.1016/j.jaip.2019.10.004 10.2500/aap.2021.42.200127 10.1159/000512944 10.20452/pamw.3273 10.2340/00015555-2350 10.2147/PPA.S86379 10.1111/pai.13065 10.2500/ar.2016.7.0165 10.1186/1710-1492-6-21 10.1111/all.13034 10.1007/s12016-016-8543-x 10.1080/1744666X.2018.1476851 10.1111/all.13270 10.1016/j.therap.2020.02.011 10.1016/j.jaip.2019.01.054 10.1056/NEJMoa0906393 10.1111/all.12900 10.1001/archinte.161.5.714 10.2500/aap.2020.41.200059 10.1111/all.12303 10.1186/s13223-019-0362-1 10.1186/1710-1492-6-24 10.1016/j.waojou.2021.100554 10.1016/j.jaip.2019.05.042 10.1111/all.13869 10.5114/ada.2020.98226 10.23822/EurAnnACI.1764-1489.204 10.1056/NEJM196906122802414 10.1111/j.1365-2249.2007.03438.x 10.1016/j.jaci.2007.02.012 10.1186/s13023-015-0233-x 10.1111/pai.13309 10.1016/j.jaip.2019.01.021 10.2500/aap.2008.29.3107 10.1016/j.jaci.2012.08.001 10.1016/0002-9343(63)90162-1 10.1210/er.2001-0014 10.1016/j.jaci.2014.08.007 10.1186/s13023-018-0832-4 10.1111/pai.13060 10.1159/000512933 10.1111/cea.13870 10.1186/1710-1492-10-50 10.1016/S0016‐3287(69)80025‐X 10.1111/all.13001 10.1186/1710-1492-6-13 10.1111/all.12209 10.1111/jth.14209 10.1016/j.jaip.2020.03.009 10.2340/00015555-3807 10.1111/j.1365-2249.2005.02726.x 10.1177/028418516500300301 10.1007/s12325-012-0053-5 10.1016/j.bbrc.2006.03.092 10.2500/aap.2014.35.3799 10.1016/j.transci.2003.08.008 10.2340/00015555-1743 10.1056/NEJM197208312870907 10.1111/all.14454 10.1186/1750-1172-9-44 10.1111/j.1471-0528.1992.tb14501.x 10.1007/s12016-016-8555-6 10.1111/all.13878 10.1016/j.jaci.2005.05.019 10.1016/j.jaci.2021.01.011 10.1007/s00108-019-0644-1 10.1159/000514973 10.2500/aap.2015.36.3892 10.2500/aap.2014.35.3783 10.1016/j.jaci.2017.05.020 10.1016/j.anai.2013.06.021 10.1111/j.1398-9995.2011.02702.x 10.1159/000329635 10.1016/j.jaip.2017.04.010 10.1155/2017/1476402 10.1016/j.anai.2018.07.025 10.1111/j.1537-2995.2011.03240.x 10.1056/NEJM197612232952602 10.2500/aap.2020.41.200058 10.2169/internalmedicine.9407-17 10.1186/1710-1492-6-18 10.18176/jiaci.0479 10.1111/all.14670 10.2147/JAA.S284029 10.2500/aap.2011.32.3440 10.1067/mai.2000.110471 10.1111/j.1537-2995.2009.02230.x 10.1186/s13023-018-0797-3 10.1111/jch.13097 10.2500/aap.2020.41.200040 10.1590/S1807-59322011000900021 10.2500/aap.2016.37.3933 10.7326/0003-4819-96-5-672 10.1111/jog.13003 10.1016/j.jaip.2021.02.026 10.1159/000351232 10.1046/j.1365-2133.1997.d01-1160.x 10.1111/adj.12447 10.1111/all.12658 10.1542/peds.2016-0575 10.2147/JAA.S200900 10.1152/ajplegacy.1949.156.2.261 10.1007/s12016-021-08852-7 10.1016/j.iac.2017.04.004 10.1016/j.jaci.2012.05.055 10.1016/j.ejogrb.2012.07.010 10.1016/S1081-1206(10)60424-3 10.1186/s13223-021-00537-2 10.1007/s12016-021-08850-9 10.1111/all.14293 10.36849/JDD.2020.5269 10.1186/s13601-015-0049-8 10.1111/j.1365-2362.2010.02402.x 10.1002/clt2.12035 10.1126/science.148.3672.957 10.1111/ced.12806 10.1016/j.tripleo.2011.02.034 10.1016/j.anai.2020.02.018 10.1080/1744666X.2018.1503055 10.2500/aap.2021.42.200106 10.1001/archinte.163.10.1229 10.1186/1477-7525-10-82 10.1111/pai.12444 10.1016/j.iac.2017.04.005 10.1016/j.jaip.2021.08.039 10.1111/j.1537-2995.2012.03590.x 10.1016/S0278-2391(99)90280-X 10.18176/jiaci.0701 10.1016/j.jclinepi.2013.12.002 10.1007/s12016-021-08843-8 10.5811/westjem.2019.5.42650 10.1007/s40261-015-0300-z 10.1016/j.jaip.2020.11.042 10.1097/00000441-198207000-00001 10.1111/ddg.12856 10.1016/j.revmed.2021.05.013 10.1111/j.1365-2222.2012.03984.x 10.1016/j.anai.2010.01.024 10.1186/1710-1492-6-22 10.1186/s13023-016-0518-8 10.1007/s00404-006-0183-6 10.1007/BF00165559 10.1111/sji.12154 10.1111/trf.12501 10.1016/j.jaip.2017.07.002 10.1016/j.clinbiochem.2017.04.007 10.1186/s13223-019-0376-8 10.1016/j.jaip.2017.12.039 10.1016/j.transci.2003.08.006 10.1016/j.amjmed.2009.02.024 10.1111/all.13076 10.1186/s12955-019-1229-3 10.1186/s40413-017-0180-1 10.1016/j.jaip.2020.02.038 10.2500/ar.2015.6.0112 10.1016/j.molimm.2008.05.007 10.1016/j.jemermed.2015.11.008 10.1016/j.iac.2013.07.006 10.1016/j.amjmed.2011.12.016 10.1016/j.jaip.2015.12.010 10.1056/NEJMoa0805538 10.1007/s12016-021-08841-w 10.1111/ced.12681 10.1111/ced.12285 10.1056/NEJMoa0905079 10.1016/j.anai.2014.05.028 10.1097/WOX.0b013e318279affa 10.1161/01.RES.11.6.910 10.1111/all.12380 10.1111/j.1365-2222.1975.tb01839.x 10.1016/j.jaci.2021.05.016 10.2500/aap.2017.38.4025 10.1016/j.alit.2019.07.005 10.1111/pde.12408 10.1016/j.jemermed.2020.09.044 10.2500/aap.2021.42.210034 10.1016/j.jaci.2016.03.043 10.1056/NEJMoa1613627 10.1016/j.anai.2020.01.009 10.1002/ccr3.3743 10.1586/1744666X.2016.1100963 10.1542/peds.2015-2411 10.1111/all.14160 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2022 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. – notice: 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. – notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC |
| DOI | 10.1111/all.15214 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1398-9995 |
| EndPage | 1990 |
| ExternalDocumentID | oai:HAL:hal-04997520v1 35006617 10_1111_all_15214 ALL15214 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Practice Guideline |
| GrantInformation_xml | – fundername: World Allergy Organization; EAACI |
| GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC |
| ID | FETCH-LOGICAL-c4224-b03680d02b6ea1c00183eb38f9e7ea06385e25c305997bb942308da73a983ca73 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 346 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000750277200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0105-4538 1398-9995 |
| IngestDate | Tue Oct 14 20:50:41 EDT 2025 Sun Nov 09 11:09:26 EST 2025 Mon Oct 06 17:42:01 EDT 2025 Thu Nov 13 04:44:22 EST 2025 Sat Nov 29 04:10:41 EST 2025 Tue Nov 18 22:18:21 EST 2025 Wed Jan 22 16:25:34 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | C1 inhibitor disease control hereditary angioedema management guideline DELPHI |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4224-b03680d02b6ea1c00183eb38f9e7ea06385e25c305997bb942308da73a983ca73 |
| Notes | Funding information LEN/HAEi network of Angioedema Centers of Reference and Excellence (ACARE 2 Funding and support of the development of this update and revision of the guideline came from WAO and EAACI. This revision and update of the guideline benefitted from the help and support of the GA Important As this is an international guideline, no information is provided regarding the licensing of the drugs mentioned for the treatment of HAE. It is in the duty of the treating physician to adhere to the relevant local regulations. ) Marcus Maurer, Markus Magerl, Stephen Betschel and Timothy Craig contributed equally. https://acare‐network.com ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| ORCID | 0000-0002-3324-7072 0000-0002-2317-4201 0000-0002-6566-4743 0000-0002-2658-0723 0000-0002-4121-481X 0000-0003-4437-0313 0000-0003-1677-8901 0000-0001-7539-6650 0000-0003-2929-1721 0000-0003-3610-9852 0000-0001-9218-5468 0000-0002-6146-0188 0000-0002-9451-3733 0000-0003-3005-9858 0000-0003-3504-2203 0000-0002-5484-364X 0000-0002-6084-4577 0000-0001-8245-4767 0000-0002-3091-7237 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.15214 |
| PMID | 35006617 |
| PQID | 2682180114 |
| PQPubID | 34098 |
| PageCount | 30 |
| ParticipantIDs | hal_primary_oai_HAL_hal_04997520v1 proquest_miscellaneous_2618503492 proquest_journals_2682180114 pubmed_primary_35006617 crossref_primary_10_1111_all_15214 crossref_citationtrail_10_1111_all_15214 wiley_primary_10_1111_all_15214_ALL15214 |
| PublicationCentury | 2000 |
| PublicationDate | July 2022 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Denmark |
| PublicationPlace_xml | – name: Denmark – name: Zurich |
| PublicationTitle | Allergy (Copenhagen) |
| PublicationTitleAlternate | Allergy |
| PublicationYear | 2022 |
| Publisher | Blackwell Publishing Ltd Wiley |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
| References | 2018; 320 1965; 148 2013; 68 1968; 3 2019; 12 2019; 15 2019; 14 2019; 17 2020; 15 2020; 13 2020; 12 2008; 100 2016; 37 2016; 36 2011; 112 2012; 10 2020; 19 2017; 72 2021; 76 2019; 20 2015; 135 2008; 29 1989; 340 1999; 57 2013; 111 2016; 42 2016; 41 2012; 29 2013; 110 2010; 5 2014; 94 2010; 6 2003; 163 2017; 62 2006; 119 2001; 161 2021; 42 2020; 41 2019; 30 1980; 65 2016; 10 2020; 37 1977; 86 2008; 54 2020; 33 2017; 376 2007; 12 2021; 51 2016; 14 1982; 284 2016; 12 2011; 9 2007; 16 2016; 11 2016; 4 2017; 50 2016; 7 1969; 280 2019; 40 1987; 336 2020; 31 2013; 76 1987; 335 2015; 114 2004; 57 2008; 45 1999; 353 2021; 61 2016; 29 2021; 60 2016; 27 2016; 26 2006; 343 2006; 101 2012; 42 2016; 9 1972; 287 2007; 149 2019; 54 1982; 96 2019; 56 2005; 139 2014; 69 2020; 58 2020; 124 2014; 63 1992; 99 2014; 67 2007; 35 2017; 118 1963; 35 2020; 8 2010; 66 2019; 60 2014; 2 1969; 1 2017; 37 2017; 38 2020; 9 2010; 152 2018; 73 2016; 116 2014; 9 1996; 334 2014; 6 2014; 54 1975; 5 2021; 9 1973; 288 2002; 36 2015; 6 2015; 5 2019; 70 2015; 3 2017; 2017 2019; 74 2011 2021; 101 2013; 43 2015; 167 2010; 126 2013; 41 2007; 120 2010; 363 1981; 68 1972; 192 2006; 274 2016; 126 2015; 7 1974; 25 2018; 2018 2007; 119 2020; 75 2013; 33 2020; 74 2021 2020 2013; 34 2017; 13 2017; 12 2008; 338 1996; 41 2020; 69 2014; 79 2017; 19 2016 2020; 112 2016; 138 2016; 137 2018; 57 2019; 2019 1983; 156 2013; 1 2021; 289 2015; 70 2010; 105 2010; 104 2002; 13 2012; 125 2014; 133 2013; 8 2012; 129 1965; 3 1974; 49 2018; 6 2012; 130 2020; 92 2000; 97 2009; 122 2011; 66 2009; 124 1949; 156 2008; 199 2010; 30 2014; 10 2019; 8 2019; 7 2010; 32 2010; 31 2000; 356 2021; 148 2010; 203 2005; 116 2016; 96 2016; 95 1962; 11 1981; 23 1991; 65 2000; 106 2015; 64 2000; 75 2003; 24 2014; 35 2003; 29 2013; 173 1882 2014; 39 2018; 11 2005; 16 2018; 16 2009; 103 2010; 50 2018; 14 2018; 13 2014; 31 2017; 5 2015; 35 2012; 162 2015; 36 2018; 121 2017; 8 2012; 165 2017; 4 2016; 71 2013; 162 2013; 161 2019; 122 2009; 49 1998; 351 2012; 52 2021; 37 2021; 31 2018; 379 2015; 44 2012; 171 2021; 195 2011; 21 1994; 35 2019; 114 2009; 161 2011; 25 2022; 77 2012; 67 2019; 112 2018; 141 1997; 136 2012; 142 2015; 10 2021; 182 2016; 51 2011; 32 2016; 50 2003; 134 1972; 1 1990; 81 2014; 112 2014; 113 2016; 55 2021; 14 1998; 38 2021; 16 2015; 26 2021; 15 2015; 25 1976; 295 2004; 114 2021; 11 2012; 157 2021; 17 2021; 19 2011; 41 2005; 53 2013; 131 2005; 59 2012; 5 1977; 5 e_1_2_17_190_1 e_1_2_17_212_1 e_1_2_17_258_1 e_1_2_17_235_1 Dinkelacker E (e_1_2_17_20_1) 1882 e_1_2_17_15_1 e_1_2_17_38_1 e_1_2_17_310_1 e_1_2_17_103_1 e_1_2_17_126_1 e_1_2_17_356_1 e_1_2_17_379_1 e_1_2_17_149_1 e_1_2_17_91_1 e_1_2_17_200_1 e_1_2_17_223_1 e_1_2_17_246_1 e_1_2_17_269_1 e_1_2_17_26_1 e_1_2_17_321_1 e_1_2_17_115_1 e_1_2_17_344_1 e_1_2_17_367_1 e_1_2_17_138_1 e_1_2_17_213_1 e_1_2_17_236_1 e_1_2_17_259_1 e_1_2_17_16_1 e_1_2_17_39_1 e_1_2_17_311_1 e_1_2_17_125_1 e_1_2_17_148_1 e_1_2_17_102_1 e_1_2_17_357_1 e_1_2_17_92_1 e_1_2_17_201_1 e_1_2_17_247_1 e_1_2_17_224_1 e_1_2_17_27_1 e_1_2_17_114_1 e_1_2_17_137_1 e_1_2_17_345_1 e_1_2_17_368_1 Proper SP (e_1_2_17_53_1) 2020; 41 e_1_2_17_80_1 Teranishi R (e_1_2_17_378_1) 2015; 64 e_1_2_17_233_1 e_1_2_17_279_1 e_1_2_17_93_1 e_1_2_17_256_1 e_1_2_17_17_1 e_1_2_17_342_1 e_1_2_17_354_1 e_1_2_17_377_1 e_1_2_17_147_1 e_1_2_17_101_1 e_1_2_17_124_1 e_1_2_17_70_1 e_1_2_17_221_1 e_1_2_17_244_1 e_1_2_17_267_1 e_1_2_17_353_1 e_1_2_17_365_1 e_1_2_17_388_1 e_1_2_17_136_1 e_1_2_17_330_1 e_1_2_17_113_1 e_1_2_17_159_1 e_1_2_17_81_1 e_1_2_17_232_1 e_1_2_17_234_1 e_1_2_17_257_1 Zanichelli A (e_1_2_17_333_1) 2015; 25 e_1_2_17_71_1 e_1_2_17_94_1 e_1_2_17_18_1 e_1_2_17_111_1 e_1_2_17_332_1 e_1_2_17_320_1 e_1_2_17_355_1 e_1_2_17_123_1 e_1_2_17_146_1 e_1_2_17_169_1 Galan HL (e_1_2_17_334_1) 1996; 41 e_1_2_17_245_1 e_1_2_17_268_1 e_1_2_17_222_1 e_1_2_17_82_1 Moldovan D (e_1_2_17_97_1) 2018; 2018 Arzneimittelkommission der deutschen Ärzteschaft (e_1_2_17_229_1) 2000; 97 e_1_2_17_29_1 e_1_2_17_331_1 e_1_2_17_343_1 e_1_2_17_366_1 e_1_2_17_112_1 e_1_2_17_135_1 e_1_2_17_158_1 e_1_2_17_210_1 Schulz KH (e_1_2_17_134_1) 1974; 25 e_1_2_17_3_1 e_1_2_17_216_1 e_1_2_17_34_1 e_1_2_17_239_1 e_1_2_17_57_1 e_1_2_17_314_1 e_1_2_17_171_1 e_1_2_17_194_1 e_1_2_17_107_1 e_1_2_17_280_1 e_1_2_17_204_1 e_1_2_17_227_1 e_1_2_17_22_1 e_1_2_17_45_1 e_1_2_17_68_1 e_1_2_17_325_1 e_1_2_17_160_1 e_1_2_17_302_1 e_1_2_17_183_1 e_1_2_17_119_1 e_1_2_17_348_1 Sankrithi P (e_1_2_17_322_1) 2020; 12 Spath PJ (e_1_2_17_305_1) 1990; 81 e_1_2_17_291_1 e_1_2_17_2_1 e_1_2_17_217_1 e_1_2_17_35_1 e_1_2_17_338_1 e_1_2_17_315_1 e_1_2_17_170_1 e_1_2_17_193_1 e_1_2_17_129_1 e_1_2_17_106_1 e_1_2_17_281_1 Fukunaga A (e_1_2_17_287_1) 2020; 69 e_1_2_17_205_1 e_1_2_17_23_1 e_1_2_17_228_1 e_1_2_17_46_1 e_1_2_17_303_1 e_1_2_17_326_1 e_1_2_17_69_1 e_1_2_17_182_1 e_1_2_17_118_1 Wu YS (e_1_2_17_270_1) 2007; 16 e_1_2_17_349_1 e_1_2_17_292_1 e_1_2_17_5_1 e_1_2_17_214_1 e_1_2_17_237_1 e_1_2_17_13_1 e_1_2_17_36_1 e_1_2_17_59_1 e_1_2_17_312_1 e_1_2_17_335_1 e_1_2_17_192_1 e_1_2_17_358_1 e_1_2_17_105_1 e_1_2_17_128_1 e_1_2_17_202_1 e_1_2_17_225_1 e_1_2_17_248_1 e_1_2_17_24_1 e_1_2_17_47_1 e_1_2_17_181_1 e_1_2_17_323_1 e_1_2_17_300_1 Blohme G (e_1_2_17_273_1) 1972; 192 e_1_2_17_346_1 e_1_2_17_369_1 e_1_2_17_117_1 Bonnekoh H (e_1_2_17_289_1) 2016 e_1_2_17_4_1 e_1_2_17_191_1 e_1_2_17_215_1 e_1_2_17_238_1 e_1_2_17_14_1 e_1_2_17_37_1 e_1_2_17_336_1 e_1_2_17_313_1 e_1_2_17_104_1 e_1_2_17_359_1 e_1_2_17_127_1 e_1_2_17_90_1 e_1_2_17_180_1 e_1_2_17_226_1 e_1_2_17_249_1 e_1_2_17_25_1 e_1_2_17_48_1 e_1_2_17_301_1 e_1_2_17_324_1 e_1_2_17_290_1 e_1_2_17_347_1 e_1_2_17_116_1 e_1_2_17_139_1 e_1_2_17_30_1 e_1_2_17_99_1 e_1_2_17_7_1 e_1_2_17_318_1 e_1_2_17_76_1 e_1_2_17_152_1 e_1_2_17_175_1 e_1_2_17_198_1 e_1_2_17_382_1 Gorman PJ (e_1_2_17_337_1) 2008; 54 e_1_2_17_261_1 e_1_2_17_284_1 e_1_2_17_41_1 e_1_2_17_64_1 e_1_2_17_87_1 e_1_2_17_329_1 e_1_2_17_208_1 e_1_2_17_164_1 e_1_2_17_306_1 e_1_2_17_187_1 e_1_2_17_370_1 e_1_2_17_141_1 e_1_2_17_272_1 e_1_2_17_295_1 e_1_2_17_54_1 e_1_2_17_77_1 e_1_2_17_31_1 e_1_2_17_6_1 e_1_2_17_319_1 e_1_2_17_174_1 e_1_2_17_197_1 e_1_2_17_360_1 e_1_2_17_383_1 e_1_2_17_151_1 Donaldson VH (e_1_2_17_58_1) 1983; 156 e_1_2_17_262_1 e_1_2_17_285_1 e_1_2_17_42_1 e_1_2_17_88_1 Caballero T (e_1_2_17_12_1) 2011; 21 e_1_2_17_307_1 e_1_2_17_65_1 Caballero T (e_1_2_17_11_1) 2011; 21 e_1_2_17_140_1 e_1_2_17_163_1 e_1_2_17_186_1 e_1_2_17_209_1 e_1_2_17_371_1 e_1_2_17_296_1 e_1_2_17_9_1 e_1_2_17_32_1 e_1_2_17_78_1 e_1_2_17_55_1 e_1_2_17_218_1 e_1_2_17_316_1 e_1_2_17_339_1 e_1_2_17_380_1 e_1_2_17_196_1 e_1_2_17_150_1 e_1_2_17_173_1 e_1_2_17_282_1 e_1_2_17_109_1 e_1_2_17_43_1 e_1_2_17_66_1 e_1_2_17_89_1 e_1_2_17_206_1 e_1_2_17_185_1 e_1_2_17_327_1 e_1_2_17_304_1 e_1_2_17_162_1 e_1_2_17_293_1 e_1_2_17_8_1 e_1_2_17_10_1 e_1_2_17_56_1 e_1_2_17_33_1 e_1_2_17_219_1 e_1_2_17_317_1 e_1_2_17_79_1 e_1_2_17_381_1 e_1_2_17_195_1 e_1_2_17_172_1 e_1_2_17_108_1 e_1_2_17_260_1 e_1_2_17_283_1 e_1_2_17_21_1 e_1_2_17_67_1 e_1_2_17_44_1 e_1_2_17_207_1 e_1_2_17_328_1 e_1_2_17_161_1 e_1_2_17_184_1 e_1_2_17_294_1 e_1_2_17_95_1 e_1_2_17_72_1 e_1_2_17_277_1 e_1_2_17_110_1 e_1_2_17_133_1 Poza Cordón J (e_1_2_17_100_1) 2020; 112 e_1_2_17_340_1 e_1_2_17_19_1 e_1_2_17_363_1 e_1_2_17_386_1 e_1_2_17_145_1 e_1_2_17_168_1 e_1_2_17_265_1 e_1_2_17_242_1 e_1_2_17_60_1 e_1_2_17_83_1 e_1_2_17_288_1 e_1_2_17_122_1 e_1_2_17_351_1 e_1_2_17_374_1 e_1_2_17_157_1 Blackmore WP (e_1_2_17_250_1) 1977; 5 e_1_2_17_230_1 e_1_2_17_253_1 e_1_2_17_276_1 e_1_2_17_50_1 e_1_2_17_73_1 e_1_2_17_96_1 e_1_2_17_255_1 e_1_2_17_278_1 e_1_2_17_155_1 e_1_2_17_132_1 Sabeen Ahmed A (e_1_2_17_130_1) 2020; 12 e_1_2_17_341_1 e_1_2_17_364_1 e_1_2_17_376_1 e_1_2_17_167_1 e_1_2_17_243_1 e_1_2_17_220_1 e_1_2_17_84_1 e_1_2_17_266_1 e_1_2_17_61_1 e_1_2_17_121_1 e_1_2_17_144_1 e_1_2_17_352_1 e_1_2_17_375_1 e_1_2_17_387_1 e_1_2_17_156_1 e_1_2_17_179_1 Nicola S (e_1_2_17_203_1) 2019; 8 e_1_2_17_254_1 e_1_2_17_231_1 e_1_2_17_74_1 e_1_2_17_51_1 e_1_2_17_154_1 e_1_2_17_177_1 e_1_2_17_361_1 e_1_2_17_384_1 e_1_2_17_131_1 e_1_2_17_189_1 e_1_2_17_240_1 e_1_2_17_286_1 e_1_2_17_263_1 e_1_2_17_62_1 e_1_2_17_85_1 e_1_2_17_308_1 e_1_2_17_166_1 e_1_2_17_143_1 e_1_2_17_372_1 e_1_2_17_120_1 Greve J (e_1_2_17_211_1) 2016; 14 e_1_2_17_178_1 e_1_2_17_297_1 e_1_2_17_251_1 e_1_2_17_274_1 e_1_2_17_52_1 Lumry WR (e_1_2_17_49_1) 2020; 41 e_1_2_17_299_1 e_1_2_17_75_1 e_1_2_17_98_1 e_1_2_17_153_1 e_1_2_17_199_1 e_1_2_17_176_1 e_1_2_17_362_1 e_1_2_17_385_1 Lundh B (e_1_2_17_271_1) 1968; 3 e_1_2_17_241_1 e_1_2_17_264_1 e_1_2_17_63_1 e_1_2_17_40_1 Obtulowicz K (e_1_2_17_28_1) 2016; 126 e_1_2_17_309_1 e_1_2_17_86_1 e_1_2_17_165_1 e_1_2_17_188_1 e_1_2_17_350_1 e_1_2_17_373_1 e_1_2_17_142_1 e_1_2_17_298_1 e_1_2_17_275_1 e_1_2_17_252_1 |
| References_xml | – volume: 14 issue: 7 year: 2021 article-title: Assessment of disease activity and quality of life in patients with recurrent bradykinin‐mediated versus mast cell‐mediated angioedema publication-title: World Allergy Organ J – volume: 45 start-page: 3536 issue: 13 year: 2008 end-page: 3544 article-title: Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates publication-title: Mol Immunol – volume: 92 start-page: 86 issue: 12 year: 2020 end-page: 90 article-title: Diagnosis and treatment of hereditary angioedema with normal C1‐inhibitor level publication-title: Ter Arkh – volume: 35 start-page: 37 year: 1963 end-page: 44 article-title: A biochemical abnormality in herediatry angioneurotic edema: absence of serum inhibitor of C' 1‐Esterase publication-title: Am J Med – volume: 8 issue: 2 year: 2013 article-title: Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment publication-title: PLoS One – volume: 156 start-page: 183 year: 1983 end-page: 191 article-title: Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma publication-title: Adv Exp Med Biol – volume: 142 start-page: 280 issue: 3 year: 2012 end-page: 290 article-title: Treatment of hereditary angioedema with nanofiltered C1‐esterase inhibitor concentrate (Cetor(R)): multi‐center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety publication-title: Clin Immunol – volume: 14 start-page: 266 issue: 3 year: 2016 end-page: 275 article-title: Prophylaxis in hereditary angioedema (HAE) with C1 inhibitor deficiency publication-title: J Dtsch Dermatol Ges – volume: 14 start-page: 707 issue: 9 year: 2018 end-page: 718 article-title: Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema publication-title: Expert Rev Clin Immunol – volume: 9 start-page: 508 issue: 1 year: 2021 end-page: 510 article-title: COVID‐19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency publication-title: J Allergy Clin Immunol Pract – volume: 9 start-page: 2151 issue: 6 year: 2021 end-page: 2157 article-title: How to measure disease activity, impact, and control in patients with recurrent wheals, angioedema, or both publication-title: J Allergy Clin Immunol Pract – volume: 75 start-page: 1165 issue: 5 year: 2020 end-page: 1177 article-title: Development of the angioedema control test‐A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema publication-title: Allergy – volume: 41 start-page: 38 issue: 1 year: 2020 end-page: 57 article-title: SERPING1 mutation update: mutation spectrum and C1 Inhibitor phenotypes publication-title: Hum Mutat – volume: 8 start-page: 901 issue: 3 year: 2020 end-page: 911 article-title: International consensus on the use of genetics in the management of hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 9 start-page: 2305 issue: 6 year: 2021 end-page: 2314. e2304 article-title: Randomized trial of the efficacy and safety of berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX‐2 through 48 weeks (Part 2) publication-title: J Allergy Clin Immunol Pract – volume: 101 start-page: 619 issue: 3 year: 2006 end-page: 627 article-title: Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency publication-title: Am J Gastroenterol – volume: 112 start-page: 418 issue: 5 year: 2020 article-title: Ultrasound findings in an abdominal crisis of a patient with hereditary angioedema publication-title: Rev Esp Enferm Dig – volume: 8 start-page: 799 issue: 2 year: 2020 end-page: 802 article-title: Recombinant human C1 esterase inhibitor as short‐term prophylaxis in patients with hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 38 start-page: 447 issue: 6 year: 2017 end-page: 455 article-title: Health‐related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden publication-title: Allergy Asthma Proc – volume: 105 start-page: 149 issue: 2 year: 2010 end-page: 154 article-title: Population pharmacokinetics of plasma‐derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks publication-title: Ann Allergy Asthma Immunol – volume: 70 start-page: 1319 issue: 10 year: 2015 end-page: 1328 article-title: Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate publication-title: Allergy – volume: 96 start-page: 672 issue: 5 year: 1982 end-page: 673 article-title: Adverse effects of danazol in pregnancy publication-title: Ann Intern Med – volume: 56 start-page: 207 issue: 2 year: 2019 end-page: 218 article-title: Update on the use of C1‐esterase inhibitor replacement therapy in the acute and prophylactic treatment of hereditary angioedema publication-title: Clin Rev Allergy Immunol – volume: 25 start-page: 447 issue: 6 year: 2015 end-page: 449 article-title: Icatibant exposure during pregnancy in a patient with hereditary angioedema publication-title: J Investig Allergol Clin Immunol – volume: 60 start-page: 35 issue: 1 year: 2021 end-page: 43 article-title: Recognition and differential diagnosis of hereditary angioedema in the emergency department publication-title: J Emerg Med – volume: 70 start-page: 1553 issue: 12 year: 2015 end-page: 1558 article-title: Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency publication-title: Allergy – volume: 10 start-page: 82 year: 2012 article-title: Development of a disease‐specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE‐QoL): Spanish multi‐centre research project publication-title: Health Qual Life Outcomes – volume: 33 start-page: 449 issue: 4 year: 2013 end-page: 456 article-title: Diagnosing angioedema publication-title: Immunol Allergy Clin North Am – volume: 73 start-page: 442 issue: 2 year: 2018 end-page: 450 article-title: Hereditary angioedema with a mutation in the plasminogen gene publication-title: Allergy – volume: 38 start-page: 540 issue: 6 year: 1998 end-page: 549 article-title: A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema publication-title: Transfusion – volume: 199 start-page: 484 issue: 5 year: 2008 article-title: Disease expression in women with hereditary angioedema publication-title: Am J Obstet Gynecol – volume: 110 start-page: 184 issue: 3 year: 2013 end-page: 188 e182 article-title: Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks publication-title: Ann Allergy Asthma Immunol – volume: 15 start-page: 20 issue: 1 year: 2021 article-title: Successful treatment with Cinryze(R) replacement therapy of a pregnant patient with hereditary angioedema: a case report publication-title: J Med Case Rep – volume: 149 start-page: 513 issue: 3 year: 2007 end-page: 516 article-title: An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema publication-title: Clin Exp Immunol – volume: 14 start-page: 65 issue: 1 year: 2019 article-title: Angioedema due to acquired C1‐inhibitor deficiency: spectrum and treatment with C1‐inhibitor concentrate publication-title: Orphanet J Rare Dis – volume: 135 start-page: 570 issue: 2 year: 2015 end-page: 573 article-title: Hereditary angioedema: molecular and clinical differences among European populations publication-title: J Allergy Clin Immunol – volume: 7 start-page: 2938 issue: 8 year: 2019 end-page: 2940 article-title: Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy publication-title: J Allergy Clin Immunol Pract – volume: 36 start-page: 399 issue: 5 year: 2015 end-page: 406 article-title: Analysis of characteristics associated with reinjection of icatibant: results from the icatibant outcome survey publication-title: Allergy Asthma Proc – volume: 42 start-page: 22 issue: 1 year: 2021 end-page: 29 article-title: Androgen use in hereditary angioedema: a critical appraisal and approaches to transitioning from androgens to other therapies publication-title: Allergy Asthma Proc – volume: 10 start-page: 1727 year: 2016 end-page: 1737 article-title: Self‐administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance publication-title: Patient Prefer Adherence – volume: 126 start-page: 821 issue: 4 year: 2010 end-page: 827 e814 article-title: Recombinant human C1‐inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 35 start-page: 184 issue: 2 year: 1994 end-page: 187 article-title: C1 inhibitor and diagnosis of hereditary angioedema in newborns publication-title: Pediatr Res – volume: 76 start-page: 1789 issue: 6 year: 2021 end-page: 1799 article-title: Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: a phase 3 randomized trial publication-title: Allergy – volume: 66 start-page: 419 issue: 4 year: 2010 end-page: 426 article-title: The effect of long‐term danazol prophylaxis on liver function in hereditary angioedema‐a longitudinal study publication-title: Eur J Clin Pharmacol – volume: 11 issue: 4 year: 2021 article-title: Long‐term safety and effectiveness of berotralstat for hereditary angioedema: the open‐label APeX‐S study publication-title: Clin Transl Allergy – volume: 75 start-page: 195 issue: 2 year: 2020 end-page: 205 article-title: Update on bradykinin‐mediated angioedema in 2020 publication-title: Therapie – volume: 161 start-page: 17 issue: Suppl 1 year: 2013 end-page: 20 article-title: Practical approach to self‐administration of intravenous C1‐INH concentrate: a nursing perspective publication-title: Int Arch Allergy Immunol – volume: 5 start-page: 1671 issue: 6 year: 2017 end-page: 1678. e1672 article-title: Treatment effect and safety of icatibant in pediatric patients with hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 101 start-page: adv00456 issue: 5 year: 2021 article-title: Patient‐reported outcome measures for angioedema: a literature review publication-title: Acta Derm Venereol – volume: 72 start-page: 320 issue: 2 year: 2017 end-page: 324 article-title: Treatment for hereditary angioedema with normal C1‐INH and specific mutations in the F12 gene (HAE‐FXII) publication-title: Allergy – volume: 35 start-page: 173 issue: 3 year: 2007 end-page: 181 article-title: Viral safety of C1‐inhibitor NF publication-title: Biologicals – volume: 114 start-page: 499 issue: 6 year: 2015 end-page: 503 article-title: Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study publication-title: Annals Allergy Asthma Immunol – volume: 3 start-page: 733 issue: 7 year: 1968 end-page: 745 article-title: A case of hereditary angioneurotic oedema, successfully treated with epsilon‐aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism publication-title: Clin Exp Immunol – volume: 70 start-page: 84 issue: 2 year: 2019 end-page: 91 article-title: Classification and pathophysiology of angioedema publication-title: Hautarzt – volume: 49 start-page: 636 issue: 8 year: 1974 end-page: 640 article-title: Therapy in hereditary angioneurotic oedema publication-title: Arch Dis Child – volume: 2019 year: 2019 article-title: Angioedema activity score (AAS): a valid and reliable tool to use in asian patients publication-title: Biomed Res Int – volume: 26 start-page: 296 issue: 3 year: 2015 end-page: 297 article-title: Use of subcutaneous‐C1 INH for acute therapy and prophylaxis of a child with HAE publication-title: Pediatr Allergy Immunol – volume: 124 start-page: 801 issue: 4 year: 2009 end-page: 808 article-title: Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks publication-title: J Allergy Clin Immunol – volume: 125 start-page: 937 issue: 9 year: 2012 article-title: Clinical impact of peripheral attacks in hereditary angioedema patients publication-title: Am J Med – volume: 36 start-page: 145 issue: 2 year: 2015 end-page: 150 article-title: Before and after, the impact of available on‐demand treatment for HAE publication-title: Allergy Asthma Proc – volume: 9 start-page: 99 issue: 2 year: 2011 end-page: 107 article-title: Long‐term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives publication-title: J Dtsch Dermatol Ges – volume: 30 start-page: 553 issue: 5 year: 2019 end-page: 561 article-title: A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema publication-title: Pediatr Allergy Immunol – volume: 54 start-page: 1552 issue: 6 year: 2014 end-page: 1561 article-title: Pharmacokinetics of plasma‐derived C1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study publication-title: Transfusion – volume: 116 start-page: 876 issue: 4 year: 2005 end-page: 883 article-title: A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 58 start-page: 279 issue: 4 year: 2020 end-page: 281 article-title: Acute presentation of undiagnosed hereditary angioedema of the larynx: averting death publication-title: Turk Arch Otorhinolaryngol – volume: 7 start-page: 1610 issue: 5 year: 2019 end-page: 1618. e1614 article-title: Fixed‐dose subcutaneous C1‐inhibitor liquid for prophylactic treatment of C1‐INH‐HAE: SAHARA randomized study publication-title: J Allergy Clin Immunol Pract – volume: 112 start-page: 58 issue: 1 year: 2011 end-page: 64 article-title: Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod – volume: 9 start-page: 3744 issue: 10 year: 2021 end-page: 3751 article-title: Lanadelumab efficacy, safety, and injection interval extension in HAE: a real‐life study publication-title: J Allergy Clin Immunol Pract – volume: 162 start-page: 1017 issue: 5 year: 2013 end-page: 1022 article-title: Nanofiltered C1‐esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1‐inhibitor deficiency in children publication-title: J Pediatr – volume: 5 start-page: 5 issue: 1 year: 2015 article-title: Clinical similarities among bradykinin‐mediated and mast cell‐mediated subtypes of non‐hereditary angioedema: a retrospective study publication-title: Clin Transl Allergy – volume: 36 start-page: 213 issue: 3 year: 2015 end-page: 217 article-title: Current state of hereditary angioedema management: a patient survey publication-title: Allergy Asthma Proc – volume: 50 start-page: 354 issue: 2 year: 2010 end-page: 360 article-title: Pharmacokinetic analysis of human plasma‐derived pasteurized C1‐inhibitor concentrate in adults and children with hereditary angioedema: a prospective study publication-title: Transfusion – volume: 130 start-page: 692 issue: 3 year: 2012 end-page: 697 article-title: Fatal laryngeal attacks and mortality in hereditary angioedema due to C1‐INH deficiency publication-title: J Allergy Clin Immunol – volume: 37 start-page: 164 issue: 2 year: 2016 end-page: 170 article-title: Risk of thromboembolism in patients with hereditary angioedema treated with plasma‐derived C1‐inhibitor publication-title: Allergy Asthma Proc – volume: 8 start-page: 2050 issue: 6 year: 2020 end-page: 2057 e2054 article-title: Validation of the angioedema control test (AECT)‐A patient‐reported outcome instrument for assessing angioedema control publication-title: J Allergy Clin Immunol Pract – volume: 15 start-page: 289 issue: 1 year: 2020 article-title: Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence publication-title: Orphanet J Rare Dis – volume: 17 start-page: 160 issue: 1 year: 2019 article-title: Angioedema quality of life questionnaire (AE‐QoL) ‐ interpretability and sensitivity to change publication-title: Health Qual Life Outcomes – volume: 96 start-page: 373 issue: 3 year: 2016 end-page: 376 article-title: Urticaria and prodromal symptoms including erythema marginatum in Danish patients with hereditary angioedema publication-title: Acta Derm Venereol – volume: 31 start-page: e132 issue: 6 year: 2014 end-page: e135 article-title: Hereditary angioedema: children should be considered for training in self‐administration publication-title: Pediatr Dermatol – volume: 16 start-page: 288 issue: 4 year: 2005 end-page: 294 article-title: Hereditary angio‐oedema in children: a management guideline publication-title: Pediatr Allergy Immunol – volume: 21 start-page: 422 issue: 6 year: 2011 end-page: 441 article-title: Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow‐up, and special situations publication-title: J Investig Allergol Clin Immunol – volume: 4 start-page: 245 year: 2017 article-title: Optimum use of acute treatments for hereditary angioedema: evidence‐based expert consensus publication-title: Front Med (Lausanne) – volume: 131 start-page: AB30 issue: 2 year: 2013 article-title: Does early clinical manifestation of hereditary angioedema (HAE) influence the clinical course of the disease? publication-title: J Allergy Clin Immun – volume: 44 start-page: 78 issue: 1 year: 2015 end-page: 88 article-title: Hereditary angioedema: treatment and educational therapeutic program publication-title: Presse Med – volume: 335 start-page: 433 issue: 4 year: 1987 end-page: 437 article-title: Analysis of the mechanism of action of bradykinin on human basilar artery in vitro publication-title: Naunyn Schmiedebergs Arch Pharmacol – volume: 66 start-page: 192 issue: 2 year: 2011 end-page: 196 article-title: Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21‐month prospective study in a cohort of 103 patients publication-title: Allergy – volume: 55 start-page: 935 issue: 10 year: 2016 end-page: 942 article-title: Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity publication-title: Clin Pediatr (Phila) – volume: 13 start-page: 153 issue: 3 year: 2002 end-page: 161 article-title: Clinical management of hereditary angio‐oedema in children publication-title: Pediatr Allergy Immunol – volume: 12 start-page: 251 issue: 3 year: 2007 end-page: 257 article-title: Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema publication-title: Helicobacter – year: 1882 – volume: 63 start-page: 173 issue: 3 year: 2014 end-page: 178 article-title: Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23–24 August 2012 publication-title: Inflamm Res – volume: 274 start-page: 381 issue: 6 year: 2006 end-page: 384 article-title: Pregnancy and C1 esterase inhibitor deficiency: a successful outcome publication-title: Arch Gynecol Obstet – volume: 52 start-page: 2104 issue: 10 year: 2012 end-page: 2112 article-title: Pathogen safety of human C1 esterase inhibitor concentrate publication-title: Transfusion – volume: 343 start-page: 1286 issue: 4 year: 2006 end-page: 1289 article-title: Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor publication-title: Biochem Biophys Res Comm – volume: 74 start-page: 1 issue: 2 year: 2020 end-page: 5 article-title: Life‐threatening laryngeal attacks in hereditary angioedema patients publication-title: Otolaryngol Pol – volume: 41 start-page: 99 issue: 2 year: 2020 end-page: 107 article-title: Manufacturing of plasma‐derived C1‐inhibitor concentrate for treatment of patients with hereditary angioedema publication-title: Allergy Asthma Proc – volume: 5 start-page: 86 year: 2010 article-title: Successful C1 inhibitor short‐term prophylaxis during redo mitral valve replacement in a patient with hereditary angioedema publication-title: J Cardiothorac Surgery – volume: 36 start-page: 16 issue: 1 year: 2016 end-page: 18 article-title: Complement study versus CINH gene testing for the diagnosis of type I hereditary angioedema in children publication-title: J Clin Immunol – volume: 9 start-page: 779 issue: 6 year: 2016 end-page: 788 article-title: Icatibant as acute treatment for hereditary angioedema in adults publication-title: Expert Rev Clin Pharmacol – volume: 114 start-page: 281 issue: 4 year: 2015 end-page: 288. e287 article-title: Critical appraisal of androgen use in hereditary angioedema: a systematic review publication-title: Ann Allergy Asthma Immunol – year: 2021 – volume: 21 start-page: 333 issue: 5 year: 2011 end-page: 347 article-title: Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis publication-title: J Investig Allergol Clin Immunol – volume: 173 start-page: 1 issue: 1 year: 2013 end-page: 7 article-title: In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency publication-title: Clin Exp Immunol – volume: 195 year: 2021 article-title: A robust multiplexed assay to quantify C1‐inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spot publication-title: J Pharm Biomed Anal – volume: 379 start-page: 352 issue: 4 year: 2018 end-page: 362 article-title: Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema publication-title: N Engl J Med – volume: 66 start-page: 1627 issue: 9 year: 2011 end-page: 1636 article-title: Brazilian guidelines for the diagnosis and treatment of hereditary angioedema publication-title: Clinics (Sao Paulo) – volume: 182 start-page: 642 issue: 7 year: 2021 end-page: 649 article-title: Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech Republic patients publication-title: Int Arch Allergy Immunol – volume: 52 start-page: 100 issue: 1 year: 2012 end-page: 107 article-title: Home therapy with intravenous human C1‐inhibitor in children and adolescents with hereditary angioedema publication-title: Transfusion – volume: 50 start-page: 816 issue: 15 year: 2017 end-page: 821 article-title: Complement factor C4 activation in patients with hereditary angioedema publication-title: Clin Biochem – volume: 6 start-page: 21 issue: 1 year: 2010 article-title: On demand treatment and home therapy of hereditary angioedema in Germany ‐ the Frankfurt experience publication-title: Allergy Asthma Clin Immunol – volume: 114 start-page: 708 issue: 8 year: 2019 end-page: 716 article-title: The ulm emergency algorithm for the acute treatment of drug‐induced, bradykinin‐mediated angioedema publication-title: Med Klin Intensivmed Notfmed – volume: 129 start-page: 308 issue: 2 year: 2012 end-page: 320 article-title: International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency publication-title: J Allergy Clin Immunol – volume: 13 start-page: 73 issue: 1 year: 2018 article-title: Epidemiology of Bradykinin‐mediated angioedema: a systematic investigation of epidemiological studies publication-title: Orphanet J Rare Dis – volume: 103 start-page: 448 issue: 5 year: 2009 article-title: Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks publication-title: Ann Allergy Asthma Immunol – volume: 53 start-page: 373 issue: 3 year: 2005 end-page: 388 article-title: Angioedema publication-title: J Am Acad Dermatol – volume: 6 start-page: 24 issue: 1 year: 2010 article-title: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema publication-title: Allergy Asthma Clin Immunol – volume: 100 start-page: 153 issue: 2 year: 2008 end-page: 161 article-title: Benefits and risks of danazol in hereditary angioedema: a long‐term survey of 118 patients publication-title: Ann Allergy Asthma Immunol – volume: 71 start-page: 1791 issue: 12 year: 2016 end-page: 1793 article-title: Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1‐inhibitor deficiency publication-title: Allergy – volume: 68 start-page: 1185 issue: 9 year: 2013 end-page: 1192 article-title: Development, validation, and initial results of the angioedema activity score publication-title: Allergy – volume: 41 start-page: 256 issue: 3 year: 2011 end-page: 262 article-title: Long‐term efficacy of danazol treatment in hereditary angioedema publication-title: Eur J Clin Invest – volume: 340 start-page: 170 issue: 2 year: 1989 end-page: 179 article-title: Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action publication-title: Naunyn Schmiedebergs Arch Pharmacol – volume: 5 start-page: 38 issue: Suppl 3 year: 1977 end-page: 43 article-title: Danazol in the treatment of hereditary angio‐neurotic oedema publication-title: J Int Med Res – volume: 37 start-page: 449 issue: 3 year: 2017 end-page: 466 article-title: The clinical evaluation of angioedema publication-title: Immunol Allergy Clin North Am – volume: 68 start-page: 1034 issue: 8 year: 2013 end-page: 1039 article-title: Risk of angioedema following invasive or surgical procedures in HAE type I and II–the natural history publication-title: Allergy – volume: 6 start-page: 839 year: 2014 end-page: 848 article-title: Management of hereditary angioedema in pregnant women: a review publication-title: Int J Womens Health – volume: 15 start-page: 72 year: 2019 article-title: The International/Canadian hereditary angioedema guideline publication-title: Allergy Asthma Clin Immunol – volume: 104 start-page: 523 issue: 6 year: 2010 end-page: 529 article-title: EDEMA4: a phase 3, double‐blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema publication-title: Ann Allergy Asthma Immunol – volume: 11 start-page: 133 issue: 1 year: 2016 article-title: High attack frequency in patients with angioedema due to C1‐inhibitor deficiency is a major determinant in switching to home therapy: a real‐life observational study publication-title: Orphanet J Rare Dis – volume: 94 start-page: 436 issue: 4 year: 2014 end-page: 441 article-title: Hereditary angioedema ‐ consequences of a new treatment paradigm in Denmark publication-title: Acta Derm Venereol – volume: 5 start-page: 89 issue: 1 year: 1975 end-page: 94 article-title: Half‐life of C1INH in hereditary angioneurotic oedema (HAE) publication-title: Clin Allergy – volume: 334 start-page: 1630 issue: 25 year: 1996 end-page: 1634 article-title: Treatment of hereditary angioedema with a vapor‐heated C1 inhibitor concentrate publication-title: N Engl J Med – volume: 119 start-page: 1497 issue: 6 year: 2007 end-page: 1503 article-title: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor‐2 antagonist (Icatibant) publication-title: J Allergy Clin Immunol – volume: 126 start-page: 76 issue: 1‐2 year: 2016 end-page: 85 article-title: Bradykinin‐mediated angioedema publication-title: Pol Arch Med Wewn – volume: 41 start-page: S43 issue: Suppl 1 year: 2020 end-page: S46 article-title: Hereditary angioedema: Special considerations in children publication-title: Allergy Asthma Proc – volume: 118 start-page: 110 issue: 1 year: 2017 end-page: 112 article-title: Short‐term prophylactic use of C1‐inhibitor concentrate in hereditary angioedema: findings from an international patient registry publication-title: Ann Allergy Asthma Immunol – volume: 42 start-page: 403 issue: 5 year: 2021 end-page: 408 article-title: Effect of COVID‐19 on hereditary angioedema activity and quality of life publication-title: Allergy Asthma Proc – volume: 29 start-page: 9 issue: 1 year: 2016 end-page: 12 article-title: High‐concentration liquid prednisolone formula: filling a therapeutic niche in severe acute attacks of Urticaria and Angioedema publication-title: Skin Pharmacol Physiol – volume: 7 start-page: 1793 issue: 6 year: 2019 end-page: 1802 e1792 article-title: Long‐term outcomes with subcutaneous C1‐inhibitor replacement therapy for prevention of hereditary angioedema attacks publication-title: J Allergy Clin Immunol Pract – volume: 41 start-page: 91 issue: 1 year: 2016 end-page: 93 article-title: Subcutaneous self‐injections of C1 inhibitor: an effective and safe treatment in a patient with hereditary angio‐oedema publication-title: Clin Exp Dermatol – volume: 76 start-page: 897 issue: 6 year: 2013 end-page: 907 article-title: Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema publication-title: Br J Clin Pharmacol – volume: 66 start-page: 588 issue: 5 year: 2011 end-page: 595 article-title: Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations publication-title: Allergy – volume: 29 start-page: 247 issue: 3 year: 2003 end-page: 254 article-title: Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.com publication-title: Transfus Apher Sci – volume: 134 start-page: 1088 issue: 8 year: 2003 end-page: 1094 article-title: Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema publication-title: J Am Dent Assoc – volume: 165 start-page: 366 issue: 2 year: 2012 end-page: 367 article-title: Successful pregnancy outcome after treatment with C1‐inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 24 start-page: 523 issue: 4 year: 2003 end-page: 538 article-title: Endocrine withdrawal syndromes publication-title: Endocr Rev – volume: 162 start-page: 319 issue: 2‐3 year: 2012 end-page: 326 article-title: Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits publication-title: J Biotechnol – volume: 60 start-page: 348 issue: 3 year: 2021 end-page: 356 article-title: Blood clotting and the pathogenesis of types I and II hereditary angioedema publication-title: Clin Rev Allergy Immunol – volume: 41 start-page: 45 issue: 1 year: 2013 end-page: 53 article-title: Angio‐oedema due to hereditary C1 inhibitor deficiency in children publication-title: Allergol Immunopathol (Madr) – volume: 2017 year: 2017 article-title: Assessment of 105 patients with angiotensin converting enzyme‐inhibitor induced angioedema publication-title: Int J Otolaryngol – volume: 67 start-page: 401 issue: 4 year: 2014 end-page: 409 article-title: Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies publication-title: J Clin Epidemiol – volume: 4 start-page: 963 issue: 5 year: 2016 end-page: 971 article-title: Safety and usage of C1‐inhibitor in hereditary angioedema: berinert registry data publication-title: J Allergy Clin Immunol Pract – volume: 6 start-page: 22 issue: 1 year: 2010 article-title: HAE international home therapy consensus document publication-title: Allergy Asthma Clin Immunol – volume: 69 start-page: 192 issue: 3 year: 2020 end-page: 203 article-title: Efficacy, pharmacokinetics, pharmacodynamics, and safety of intravenous C1 inhibitor for long‐term prophylaxis and treatment of breakthrough attacks in Japanese subjects with hereditary angioedema: a phase 3 open‐label study publication-title: Arerugi – volume: 27 start-page: 223 issue: 2 year: 2016 end-page: 224 article-title: Daily subcutaneous administration of human C1 inhibitor in a child with hereditary angioedema type 1 publication-title: Pediatr Allergy Immunol – volume: 356 start-page: 213 issue: 9225 year: 2000 end-page: 217 article-title: Hereditary angioedema with normal C1‐inhibitor activity in women publication-title: Lancet – volume: 30 start-page: 562 issue: 5 year: 2019 end-page: 568 article-title: Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children publication-title: Pediatr Allergy Immunol – volume: 77 start-page: 979 issue: 3 year: 2022 end-page: 990 article-title: Long‐term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE study publication-title: Allergy – volume: 32 start-page: 319 issue: 4 year: 2011 end-page: 324 article-title: Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: results from the EDEMA clinical trials publication-title: Allergy Asthma Proc – volume: 113 start-page: 198 issue: 2 year: 2014 end-page: 203 article-title: A cross‐sectional questionnaire assessing patient and physician use of short‐term prophylaxis for hereditary angioedema publication-title: Annals Allergy Asthma Immunol – volume: 65 start-page: 134 issue: 2 year: 1991 end-page: 138 article-title: C1‐esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia publication-title: Thromb Haemost – volume: 338 start-page: 14 issue: 1‐2 year: 2008 end-page: 20 article-title: Functional C1‐inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations publication-title: J Immunol Methods – volume: 61 start-page: 60 issue: 1 year: 2021 end-page: 65 article-title: Unnecessary abdominal surgeries in attacks of hereditary angioedema with normal C1 inhibitor publication-title: Clin Rev Allergy Immunol – volume: 35 start-page: 444 issue: 6 year: 2014 end-page: 453 article-title: The thrombogenicity of C1 esterase inhibitor (human): review of the evidence publication-title: Allergy Asthma Proc – volume: 15 start-page: 52 issue: 1 year: 2020 article-title: Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene publication-title: Orphanet J Rare Dis – volume: 280 start-page: 1356 issue: 24 year: 1969 end-page: 1357 article-title: The "neurotic edema" (hereditary angioedema) publication-title: N Engl J Med – volume: 131 start-page: 579 issue: 2 year: 2013 end-page: 582 article-title: Prophylactic therapy in children with hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 51 start-page: 170 issue: 2 year: 2016 end-page: 182 article-title: Genetics of hereditary angioedema revisited publication-title: Clin Rev Allergy Immunol – volume: 31 start-page: 356 issue: 4 year: 2021 end-page: 357 article-title: Psychiatric and clinical characteristics of hereditary angioedema patients who experienced attacks during COVID‐19 publication-title: J Investig Allergol Clin Immunol – volume: 1 start-page: 408 issue: 5 year: 1969 end-page: 426 article-title: Experimental study of group opinion ‐ Delphi method publication-title: Futures – volume: 289 start-page: 547 issue: 4 year: 2021 end-page: 558 article-title: A follow‐up survey of patients with acquired angioedema due to C1‐inhibitor deficiency publication-title: J Intern Med – volume: 42 start-page: 274 issue: 4 year: 2021 end-page: 282 article-title: Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: review of phase II and III studies publication-title: Allergy Asthma Proc – volume: 104 start-page: 314 issue: 4 year: 2010 end-page: 320 article-title: Economic costs associated with acute attacks and long‐term management of hereditary angioedema publication-title: Ann Allergy Asthma Immunol – volume: 7 start-page: 739 issue: 7 year: 2015 end-page: 752 article-title: Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency publication-title: Immunotherapy – year: 2020 – volume: 12 issue: 9 year: 2019 article-title: Fresh frozen plasma for on‐demand hereditary angioedema treatment in South Africa and Iran publication-title: World Allergy Organ J – volume: 57 start-page: 213 issue: 2 year: 2004 end-page: 214 article-title: Normal complement C4 values do not exclude hereditary angioedema publication-title: J Clin Pathol – volume: 3 start-page: 206 issue: 2 year: 2015 end-page: 212. e204 article-title: Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks publication-title: J Allergy Clin Immunol Pract – volume: 61 start-page: 15 issue: 1 year: 2021 end-page: 28 article-title: The enigma of prodromes in hereditary angioedema (HAE) publication-title: Clin Rev Allergy Immunol – volume: 37 start-page: 597 issue: 3 year: 2017 end-page: 616 article-title: Burden of illness and quality‐of‐life measures in angioedema conditions publication-title: Immunol Allergy Clin North Am – volume: 163 start-page: 1229 issue: 10 year: 2003 end-page: 1235 article-title: Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency publication-title: Arch Intern Med – volume: 12 start-page: 55 issue: 1 year: 2017 article-title: Clinical characteristics and real‐life diagnostic approaches in all Danish children with hereditary angioedema publication-title: Orphanet J Rare Dis – volume: 12 issue: 8 year: 2020 article-title: Novel use of Fresh Frozen plasma in treating hereditary angioedema: a success story from Pakistan publication-title: Cureus – volume: 19 start-page: eRW5498 year: 2021 article-title: Hereditary angioedema: how to approach it at the emergency department? publication-title: Einstein (Sao Paulo) – volume: 9 start-page: 205 year: 2014 article-title: Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema publication-title: Orphanet J Rare Dis – volume: 111 start-page: 211 issue: 3 year: 2013 end-page: 215 article-title: Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks publication-title: Ann Allergy Asthma Immunol – year: 2011 – volume: 287 start-page: 452 issue: 9 year: 1972 end-page: 454 article-title: Tranexamic acid therapy in hereditary angioneurotic edema publication-title: N Engl J Med – volume: 376 start-page: 717 issue: 8 year: 2017 end-page: 728 article-title: Inhibiting plasma kallikrein for hereditary angioedema prophylaxis publication-title: N Engl J Med – volume: 69 start-page: 602 issue: 5 year: 2014 end-page: 616 article-title: Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group publication-title: Allergy – volume: 124 start-page: 394 issue: 4 year: 2020 end-page: 395. e391 article-title: Contact system activation during erythema marginatum in hereditary angioedema publication-title: Ann Allergy Asthma Immunol – volume: 122 start-page: 666 issue: 6 year: 2019 end-page: 667 article-title: Chronic spontaneous urticaria and angioedema requiring treatment with omalizumab in a patient with hereditary angioedema publication-title: Ann Allergy Asthma Immunol – volume: 10 start-page: 50 issue: 1 year: 2014 article-title: Canadian hereditary angioedema guideline publication-title: Allergy Asthma Clin Immunol – volume: 106 start-page: 1147 issue: 6 year: 2000 end-page: 1154 article-title: Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema publication-title: J Allergy Clin Immunol – volume: 65 start-page: 75 issue: 1 year: 1980 end-page: 79 article-title: Danazol and stanozolol in long‐term prophylactic treatment of hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 11 start-page: 5 year: 2018 article-title: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update publication-title: World Allergy Organization J – volume: 61 start-page: 50 issue: 1 year: 2021 end-page: 59 article-title: How angioedema quality of life questionnaire can help physicians in treating C1‐inhibitor deficiency patients? publication-title: Clin Rev Allergy Immunol – volume: 6 start-page: 18 issue: 1 year: 2010 article-title: Pediatric hereditary angioedema due to C1‐inhibitor deficiency publication-title: Allergy Asthma Clin Immunol – volume: 26 start-page: 383 issue: 6 year: 2016 end-page: 386 article-title: Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema publication-title: J Investig Allergol Clin Immunol – volume: 8 start-page: 178 issue: 3 year: 2017 end-page: 181 article-title: Multiple doses of icatibant used during pregnancy publication-title: Allergy Rhinol (Providence) – volume: 81 start-page: 513 issue: 7‐8 year: 1990 end-page: 531 article-title: A review on the acquired, allergic or non‐allergic, and the hereditary forms publication-title: Recenti Prog Med – volume: 182 start-page: 585 issue: 7 year: 2021 end-page: 591 article-title: The challenges in the follow‐up and treatment of brazilian children with hereditary angioedema publication-title: Int Arch Allergy Immunol – volume: 4 start-page: 464 issue: 3 year: 2016 end-page: 473 e464 article-title: Psychometric field study of hereditary angioedema quality of life questionnaire for adults: HAE‐QoL publication-title: J Allergy Clin Immunol Pract – volume: 41 start-page: 838 issue: 12 year: 2020 end-page: 842 article-title: Acquired angioedema due to C1‐inhibitor deficiency: CREAK recommendations for diagnosis and treatment publication-title: Rev Med Interne – volume: 23 start-page: 453 issue: 4‐5 year: 1981 end-page: 455 article-title: C1 inactivator level in pregnancy publication-title: Thromb Res – volume: 61 start-page: 29 issue: 1 year: 2021 end-page: 39 article-title: New instrument for the evaluation of prodromes and attacks of hereditary angioedema (HAE‐EPA) publication-title: Clin Rev Allergy Immunol – volume: 6 start-page: 277 issue: 1 year: 2018 end-page: 279 e271 article-title: Hereditary angioedema in 2 sisters due to paternal gonadal mosaicism publication-title: J Allergy Clin Immunol Pract – volume: 156 start-page: 261 issue: 2 year: 1949 end-page: 273 article-title: Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin publication-title: Am J Physiol – volume: 9 start-page: 44 year: 2014 article-title: The influence of trigger factors on hereditary angioedema due to C1‐inhibitor deficiency publication-title: Orphanet J Rare Dis – volume: 86 start-page: 306 issue: 3 year: 1977 end-page: 308 article-title: Methyltestosterone therapy in hereditary angioedema publication-title: Ann Intern Med – volume: 13 start-page: 153 year: 2020 end-page: 158 article-title: Self‐management plans in patients with hereditary angioedema: strategies, outcomes and integration into clinical care publication-title: J Asthma Allergy – volume: 33 start-page: 495 issue: 4 year: 2013 end-page: 503 article-title: Update on preventive therapy (prophylaxis) for hereditary angioedema publication-title: Immunol Allergy Clin North Am – volume: 131 start-page: 909 issue: 3 year: 2013 end-page: 911 article-title: Treatment of attacks with plasma‐derived C1‐inhibitor concentrate in pediatric hereditary angioedema patients publication-title: J Allergy Clin Immunol – volume: 36 start-page: 707 issue: 5 year: 2002 end-page: 709 article-title: Danazol‐induced hepatocellular adenoma in patients with hereditary angio‐oedema publication-title: J Hepatol – volume: 97 start-page: A‐1016 issue: 15 year: 2000 article-title: Schwerwiegende thrombenbildung nach Berinert® HS publication-title: Deutsches Ärzteblatt – volume: 39 start-page: 298 issue: 3 year: 2014 end-page: 303 article-title: Characterization of prodromal symptoms in a large population of patients with hereditary angio‐oedema publication-title: Clin Exp Dermatol – volume: 33 start-page: 907 issue: 6 year: 2020 end-page: 911 article-title: Successful long‐term prophylactic treatment with subcutaneous C1 esterase inhibitor in a patient with hereditary angioedema publication-title: J Pharm Pract – volume: 72 start-page: 300 issue: 2 year: 2017 end-page: 313 article-title: International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency publication-title: Allergy – volume: 68 start-page: 181 issue: 3 year: 1981 end-page: 187 article-title: Clinical and biochemical effects of stanozolol therapy for hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 376 start-page: 1131 issue: 12 year: 2017 end-page: 1140 article-title: Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor publication-title: N Engl J Med – volume: 66 start-page: 1604 issue: 12 year: 2011 end-page: 1611 article-title: C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks–final results of the I.M.P.A.C.T.2 study publication-title: Allergy – volume: 7 start-page: 172 issue: 3 year: 2016 end-page: 181 article-title: Expert perspectives on hereditary angioedema: key areas for advancements in care across the patient journey publication-title: Allergy Rhinol (Providence) – volume: 141 start-page: 1009 issue: 3 year: 2018 end-page: 1017 article-title: Mutation of the angiopoietin‐1 gene (ANGPT1) associates with a new type of hereditary angioedema publication-title: J Allergy Clin Immun – volume: 336 start-page: 430 issue: 4 year: 1987 end-page: 433 article-title: Analysis of the receptors mediating vascular actions of bradykinin publication-title: Naunyn Schmiedebergs Arch Pharmacol – volume: 363 start-page: 513 issue: 6 year: 2010 end-page: 522 article-title: Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema publication-title: N Engl J Med – volume: 42 start-page: 608 issue: 9 year: 2021 end-page: 615 article-title: Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patientsImpact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema. Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema publication-title: Rev Med Interne – volume: 67 start-page: 147 issue: 2 year: 2012 end-page: 157 article-title: Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group publication-title: Allergy – volume: 14 start-page: 119 year: 2021 end-page: 125 article-title: Optimal management of hereditary angioedema: shared decision‐making publication-title: J Asthma Allergy – volume: 31 start-page: 511 issue: 6 year: 2010 end-page: 519 article-title: The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007 publication-title: Allergy Asthma Proc – volume: 67 start-page: 1289 issue: 10 year: 2012 end-page: 1298 article-title: Development and construct validation of the angioedema quality of life questionnaire publication-title: Allergy – volume: 12 issue: 5 year: 2020 article-title: Pregnancy‐induced exacerbation of hereditary angioedema in a multiparous caucasian female publication-title: Cureus – volume: 37 start-page: 571 issue: 3 year: 2017 end-page: 584 article-title: Hereditary angioedema with normal C1 inhibitor: update on evaluation and treatment publication-title: Immunol Allergy Clin North Am – volume: 10 start-page: 11 year: 2015 article-title: A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy publication-title: Orphanet J Rare Dis – volume: 19 start-page: 1377 issue: 12 year: 2017 end-page: 1382 article-title: Angiotensin‐converting enzyme inhibitor‐induced angioedema: a review of the literature publication-title: J Clin Hypertens (Greenwich) – volume: 42 start-page: 205 issue: 3 year: 2021 end-page: 213 article-title: Short‐term prophylaxis for children and adolescents with hereditary angioedema publication-title: Allergy Asthma Proc – volume: 35 start-page: 407 issue: 7 year: 2015 end-page: 417 article-title: Recombinant human C1 esterase inhibitor in the management of hereditary angioedema publication-title: Clin Drug Investig – volume: 9 start-page: 3402 issue: 11 year: 2020 article-title: Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor publication-title: J Clin Med – volume: 17 start-page: 40 issue: 1 year: 2021 article-title: Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report publication-title: Allergy Asthma Clin Immunol – volume: 38 start-page: 216 issue: 3 year: 2017 end-page: 221 article-title: Safety of a C1‐inhibitor concentrate in pregnant women with hereditary angioedema publication-title: Allergy Asthma Proc – volume: 19 start-page: 3 issue: 1 year: 2021 article-title: Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene publication-title: Clin Mol Allergy – volume: 203 start-page: 131 issue: 2 year: 2010 article-title: Characterization of acute hereditary angioedema attacks during pregnancy and breast‐feeding and their treatment with C1 inhibitor concentrate publication-title: Am J Obstet Gynecol – volume: 171 start-page: 1339 year: 2012 end-page: 1348 article-title: Hereditary angioedema (HAE) in children and adolescents‐a consensus on therapeutic strategies publication-title: Eur J Pediatr – volume: 29 start-page: 239 issue: 3 year: 2003 end-page: 245 article-title: Diagnosis and management of hereditary angioedema: an American approach publication-title: Transfus Apher Sci – volume: 69 start-page: 305 issue: 3 year: 2014 end-page: 314 article-title: Open‐label, multicenter study of self‐administered icatibant for attacks of hereditary angioedema publication-title: Allergy – volume: 73 start-page: 1393 issue: 7 year: 2018 end-page: 1414 article-title: The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria publication-title: Allergy – volume: 71 start-page: 1203 issue: 8 year: 2016 end-page: 1209 article-title: The angioedema quality of life questionnaire (AE‐QoL) ‐ assessment of sensitivity to change and minimal clinically important difference publication-title: Allergy – volume: 64 start-page: 441 issue: 4 year: 2015 end-page: 443 article-title: Perioperative management of a patient with hereditary angioedema: a case report publication-title: Masui – volume: 9 start-page: 1273 issue: 3 year: 2021 end-page: 1275 article-title: Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE publication-title: Clin Case Rep – volume: 34 start-page: 162 issue: 2 year: 2013 end-page: 169 article-title: Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women publication-title: Allergy Asthma Proc – volume: 112 start-page: 163 issue: 2 year: 2014 end-page: 169. e161 article-title: Recombinant human C1‐esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo‐controlled trial publication-title: Ann Allergy Asthma Immunol – volume: 353 start-page: 1066 issue: 9158 year: 1999 end-page: 1067 article-title: Hepatocellular adenomas in patients taking danazol for hereditary angio‐oedema publication-title: Lancet – volume: 69 start-page: 148 issue: 1 year: 2020 end-page: 149 article-title: A novel C1 inhibitor gene mutation in a family with hereditary angioedema: use of genetic analysis to facilitate early diagnosis publication-title: Allergol Int – volume: 51 start-page: 207 issue: 2 year: 2016 end-page: 215 article-title: Complement, kinins, and hereditary angioedema: mechanisms of plasma instability when C1 inhibitor is absent publication-title: Clin Rev Allergy Immunol – volume: 11 start-page: 910 year: 1962 end-page: 915 article-title: Coronary vasodilation produced by bradykinin on isolated mammalian heart publication-title: Circ Res – volume: 41 start-page: S30 issue: Suppl 1 year: 2020 end-page: S34 article-title: Triggers and short‐term prophylaxis in patients with hereditary angioedema publication-title: Allergy Asthma Proc – year: 2016 – volume: 121 start-page: 673 issue: 6 year: 2018 end-page: 679 article-title: Long‐term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency publication-title: Ann Allergy Asthma Immunol – volume: 138 issue: 5 year: 2016 article-title: Management of children with hereditary angioedema due to C1 inhibitor deficiency publication-title: Pediatrics – volume: 37 start-page: 445 issue: 4 year: 2020 end-page: 451 article-title: Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA) publication-title: Postepy Dermatol Alergol – volume: 42 start-page: 108 issue: 2 year: 2021 end-page: 117 article-title: Assessing the cost and quality‐of‐life impact of on‐demand‐only medications for adults with hereditary angioedema publication-title: Allergy Asthma Proc – volume: 25 start-page: 12 issue: 1 year: 1974 end-page: 16 article-title: Hereditary Quincke's edema. New therapeutic ways publication-title: Hautarzt – volume: 41 start-page: S38 issue: Suppl 1 year: 2020 end-page: S42 article-title: Hereditary angioedema: Comprehensive management plans and patient support publication-title: Allergy Asthma Proc – volume: 6 start-page: 1132 issue: 4 year: 2018 end-page: 1141 article-title: Angioedema due to bradykinin dysregulation publication-title: J Allergy Clin Immunol Pract – volume: 33 start-page: 505 issue: 4 year: 2013 end-page: 511 article-title: Hereditary angioedema in women: specific challenges publication-title: Immunol Allergy Clin North Am – volume: 148 start-page: 1041 issue: 4 year: 2021 end-page: 1048 article-title: Novel hereditary angioedema linked with a heparan sulfate 3‐O‐sulfotransferase 6 gene mutation publication-title: J Allergy Clin Immunol – volume: 49 start-page: 1987 issue: 9 year: 2009 end-page: 1995 article-title: C1‐inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis publication-title: Transfusion – volume: 2018 year: 2018 article-title: Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian registry publication-title: Case Rep Emerg Med – volume: 41 start-page: S08 issue: Suppl 1 year: 2020 end-page: S13 article-title: Hereditary angioedema: epidemiology and burden of disease publication-title: Allergy Asthma Proc – volume: 152 start-page: 44 issue: 1 year: 2010 end-page: 49 article-title: The natural history of hereditary angioedema and the impact of treatment with human C1‐inhibitor concentrate during pregnancy: a long‐term survey publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 34 start-page: 519 issue: 6 year: 2013 end-page: 522 article-title: Assessment of hereditary angioedema treatment risks publication-title: Allergy Asthma Proc – volume: 37 start-page: 218 issue: 4 year: 2021 end-page: 223 article-title: Recognition, evaluation, and management of pediatric hereditary angioedema publication-title: Pediatr Emerg Care – volume: 161 start-page: 1153 issue: 5 year: 2009 end-page: 1158 article-title: Hereditary angio‐oedema in Denmark: a nationwide survey publication-title: Br J Dermatol – volume: 30 start-page: 823 issue: 6 year: 2010 end-page: 829 article-title: Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema publication-title: J Clin Immunol – volume: 4 start-page: 212 year: 2017 article-title: Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema publication-title: Front Med (Lausanne) – volume: 31 start-page: 974 issue: 8 year: 2020 end-page: 989 article-title: Hereditary angioedema in children and adolescents ‐ A consensus update on therapeutic strategies for German‐speaking countries publication-title: Pediatr Allergy Immunol – volume: 54 start-page: 365 issue: 3 year: 2008 end-page: 366 article-title: Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate publication-title: Can Fam Physician Med Fam Can – volume: 138 start-page: 934 issue: 3 year: 2016 end-page: 936. e935 article-title: Prophylaxis of hereditary angioedema attacks: a randomized trial of oral plasma kallikrein inhibition with avoralstat publication-title: J Allergy Clin Immunol – volume: 6 start-page: 1733 issue: 5 year: 2018 end-page: 1741. e1733 article-title: Health‐related quality of life with subcutaneous C1‐inhibitor for prevention of attacks of hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 161 start-page: 714 issue: 5 year: 2001 end-page: 718 article-title: Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema publication-title: Arch Intern Med – volume: 59 start-page: 594 issue: 5 year: 2005 end-page: 599 article-title: Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? publication-title: Int J Clin Pract – volume: 288 start-page: 53 issue: 1 year: 1973 article-title: Tranexamic acid in hereditary angioneurotic edema–a progress report publication-title: N Engl J Med – volume: 67 start-page: 1586 issue: 12 year: 2012 end-page: 1593 article-title: Short‐term prophylaxis in hereditary angioedema due to deficiency of the C1‐inhibitor–a long‐term survey publication-title: Allergy – volume: 14 start-page: 447 issue: 6 year: 2018 end-page: 460 article-title: Icatibant for the treatment of hereditary angioedema with C1‐inhibitor deficiency in adolescents and in children aged over 2 years publication-title: Expert Rev Clin Immunol – volume: 363 start-page: 532 issue: 6 year: 2010 end-page: 541 article-title: Icatibant, a new bradykinin‐receptor antagonist, in hereditary angioedema publication-title: N Engl J Med – volume: 295 start-page: 1444 issue: 26 year: 1976 end-page: 1448 article-title: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities publication-title: N Engl J Med – volume: 79 start-page: 276 issue: 4 year: 2014 end-page: 281 article-title: Complement profile in neonates of different gestational ages publication-title: Scand J Immunol – volume: 182 start-page: 1 year: 2021 end-page: 8 article-title: Prophylactic treatment in hereditary angioedema is associated with reduced anxiety in patients in Leipzig, Germany publication-title: Int Arch Allergy Immunol – volume: 122 start-page: 780 issue: 8 year: 2009 end-page: 783 article-title: Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate publication-title: Am J Med – volume: 2 start-page: 77 issue: 1 year: 2014 end-page: 84 article-title: Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 54 start-page: 377 issue: 6 year: 2019 end-page: 394 article-title: The impact of hereditary angioedema on quality of life and family planning decisions publication-title: Int J Psychiatry Med – volume: 36 start-page: 92 issue: 2 year: 2015 end-page: 99 article-title: Facilitating home‐based treatment of hereditary angioedema publication-title: Allergy Asthma Proc – volume: 13 start-page: 779 issue: 7 year: 2020 end-page: 786 article-title: Thromboembolic risk of C1 esterase inhibitors: a systematic review on current evidence publication-title: Expert Rev Clin Pharmacol – volume: 42 start-page: 929 issue: 6 year: 2012 end-page: 935 article-title: Efficacy and safety of recombinant human C1‐inhibitor for the treatment of attacks of hereditary angioedema: european open‐label extension study publication-title: Clin Exp Allergy – volume: 284 start-page: 2 issue: 1 year: 1982 end-page: 9 article-title: Hereditary angioedema: an appraisal of 104 cases publication-title: Am J Med Sci – volume: 60 start-page: 987 issue: 9 year: 2019 end-page: 995 article-title: Hereditary angioedema publication-title: Der Internist – volume: 12 start-page: 19 issue: 1 year: 2016 end-page: 31 article-title: Optimizing hereditary angioedema management through tailored treatment approaches publication-title: Expert Rev Clin Immunol – volume: 73 start-page: 1575 issue: 8 year: 2018 end-page: 1596 article-title: The international WAO/EAACI guideline for the management of hereditary angioedema‐The 2017 revision and update publication-title: Allergy – volume: 25 start-page: 373 issue: 6 year: 2011 end-page: 378 article-title: Pathophysiology of hereditary angioedema publication-title: Am J Rhinol Allergy – volume: 16 start-page: 86 issue: 1 year: 2021 article-title: Long‐term health‐related quality of life in patients treated with subcutaneous C1‐inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open‐label extension study publication-title: Orphanet J Rare Dis – volume: 31 start-page: 246 issue: 3 year: 2021 end-page: 252 article-title: HAE‐AS: a specific disease activity scale for hereditary angioedema with C1‐inhibitor deficiency publication-title: J Investig Allergol Clin Immunol – volume: 35 start-page: 250 issue: 3 year: 2014 end-page: 254 article-title: Barriers to self‐administered therapy for hereditary angioedema publication-title: Allergy Asthma Proc – volume: 148 start-page: 164 issue: 1 year: 2021 end-page: 172. e169 article-title: Oral once‐daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double‐blind, placebo‐controlled phase 3 trial publication-title: J Allergy Clin Immunol – volume: 73 start-page: 1871 issue: 9 year: 2018 end-page: 1880 article-title: Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPuS‐2 study publication-title: Allergy – volume: 9 start-page: 947 issue: 2 year: 2021 end-page: 955 article-title: The importance of complement testing in acquired angioedema related to angiotensin‐converting enzyme inhibitors publication-title: J Allergy Clin Immunol Pract – volume: 9 start-page: 132 issue: 1 year: 2021 end-page: 150 e133 article-title: US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 26 start-page: 674 issue: 7 year: 2015 end-page: 680 article-title: Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema publication-title: Pediatr Allergy Immunol – volume: 9 start-page: 407 issue: 8 year: 2014 end-page: 410 article-title: Outcome following tranexamic acid exposure during breastfeeding publication-title: Breastfeed Med – volume: 61 start-page: 84 issue: 1 year: 2021 end-page: 97 article-title: Mitigating disparity in health‐care resources between countries for management of hereditary angioedema publication-title: Clin Rev Allergy Immunol – volume: 136 start-page: 153 issue: 2 year: 1997 end-page: 158 article-title: Angiotensin‐converting enzyme (ACE) inhibitors and angio‐oedema publication-title: Br J Dermatol – volume: 116 start-page: 476 issue: 5 year: 2016 end-page: 477 article-title: Real‐life experience with long‐term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: effectiveness and cost publication-title: Ann Allergy Asthma Immunol – volume: 16 start-page: 1674 issue: 9 year: 2018 end-page: 1685 article-title: Hereditary angioedema: the plasma contact system out of control publication-title: J Thromb Haemost – volume: 75 start-page: 2879 issue: 11 year: 2020 end-page: 2887 article-title: Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks publication-title: Allergy – volume: 75 start-page: 2115 issue: 8 year: 2020 end-page: 2123 article-title: Definition, aims, and implementation of GA(2) LEN/HAEi Angioedema Centers of Reference and Excellence publication-title: Allergy – volume: 33 start-page: 471 issue: 4 year: 2013 end-page: 485 article-title: Creating a comprehensive treatment plan for hereditary angioedema publication-title: Immunol Allergy Clin North Am – volume: 9 start-page: 4156 issue: 11 year: 2021 end-page: 4158 article-title: COVID‐19 vaccination and the risk of swellings in patients with hereditary angioedema publication-title: J Allergy Clin Immunol Pract – volume: 139 start-page: 379 issue: 3 year: 2005 end-page: 394 article-title: C1 inhibitor deficiency: consensus document publication-title: Clin Exp Immunol – volume: 51 start-page: 947 issue: 7 year: 2021 end-page: 950 article-title: COVID‐19 as a trigger of acute attacks in people with hereditary angioedema publication-title: Clin Exp Allergy – year: 2021 article-title: Acute urticaria in children: from pediatric emergency department to allergology consultation at a central hospital publication-title: Eur Ann Allergy Clin Immunol – volume: 1 start-page: 458 issue: 5 year: 2013 end-page: 467 article-title: US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency publication-title: J Allergy Clin Immunol Pract – volume: 96 start-page: 574 issue: 4 year: 2016 end-page: 575 article-title: Urticaria as a presenting prodromal manifestation of attacks of hereditary angioedema publication-title: Acta Derm Venereol – volume: 8 start-page: 212605 year: 2019 article-title: Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research publication-title: Drugs Context – volume: 42 start-page: 1026 issue: 8 year: 2016 end-page: 1028 article-title: First report of icatibant treatment in a pregnant patient with hereditary angioedema publication-title: J Obstet Gynaecol Res – volume: 167 start-page: 21 issue: 1 year: 2015 end-page: 28 article-title: Treatment of HAE attacks in the Icatibant outcome survey: an analysis of Icatibant self‐administration versus administration by Health Care Professionals publication-title: Int Arch Allergy Immunol – volume: 137 issue: 2 year: 2016 article-title: Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns publication-title: Pediatrics – volume: 95 issue: 33 year: 2016 article-title: A nationwide study of acquired C1‐inhibitor deficiency in France: characteristics and treatment responses in 92 patients publication-title: Medicine (Baltimore) – volume: 112 start-page: 378 year: 2019 end-page: 386 article-title: Hereditary angioedema: insights into inflammation and allergy publication-title: Mol Immunol – volume: 192 start-page: 293 issue: 4 year: 1972 end-page: 298 article-title: Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double‐blind cross‐over study publication-title: Acta Med Scand – volume: 100 start-page: S30 issue: 1 Suppl 2 year: 2008 end-page: S40 article-title: Hereditary angiodema: a current state‐of‐the‐art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema publication-title: Ann Allergy Asthma Immunol – volume: 74 start-page: 2550 issue: 12 year: 2019 end-page: 2553 article-title: Diagnosis and treatment of chronic inducible urticaria publication-title: Allergy – volume: 119 start-page: 267 issue: 3 year: 2006 end-page: 274 article-title: Hereditary angioedema: new findings concerning symptoms, affected organs, and course publication-title: Am J Med – volume: 161 start-page: 3 issue: Suppl 1 year: 2013 end-page: 9 article-title: Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self‐administration publication-title: Int Arch Allergy Immunol – volume: 13 start-page: 90 issue: 1 year: 2018 article-title: Food as a trigger for abdominal angioedema attacks in patients with hereditary angioedema publication-title: Orphanet J Rare Dis – volume: 40 start-page: 279 issue: 4 year: 2019 end-page: 281 article-title: Hereditary angioedema: Screening of first‐degree blood relatives and earlier diagnosis publication-title: Allergy Asthma Proc – volume: 6 start-page: 13 issue: 1 year: 2010 article-title: Hereditary angioedema consensus 2010 publication-title: Allergy Asthma Clin Immunol – volume: 5 start-page: 1307 issue: 5 year: 2017 end-page: 1313 article-title: Diagnosis, course, and management of angioedema in patients with acquired C1‐inhibitor deficiency publication-title: J Allergy Clin Immunol Pract – volume: 113 start-page: 460 issue: 4 year: 2014 end-page: 466. e462 article-title: A phase 1 study investigating DX‐2930 in healthy subjects publication-title: Ann Allergy Asthma Immunol – volume: 16 start-page: 94 issue: 1 year: 2021 article-title: Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey publication-title: Orphanet J Rare Dis – volume: 29 start-page: 913 issue: 10 year: 2012 end-page: 922 article-title: Per‐attack reporting of prodromal symptoms concurrent with C1‐inhibitor treatment of hereditary angioedema attacks publication-title: Adv Ther – volume: 6 start-page: 50 issue: 1 year: 2015 end-page: 55 article-title: Perioperative management for patients with hereditary angioedema publication-title: Allergy Rhinol (Providence) – volume: 26 start-page: 161 issue: 3 year: 2016 end-page: 167 article-title: Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency publication-title: J Investig Allergol Clin Immunol – volume: 148 start-page: 957 issue: 3672 year: 1965 end-page: 958 article-title: Hereditary angioneurotic edema: two genetic variants publication-title: Science – volume: 133 start-page: 1270 issue: 5 year: 2014 end-page: 1277 article-title: The diagnosis and management of acute and chronic urticaria: 2014 update publication-title: J Allergy Clin Immunol – volume: 76 start-page: 1188 issue: 4 year: 2021 end-page: 1198 article-title: Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study publication-title: Allergy – volume: 44 start-page: 526 issue: 5 year: 2015 end-page: 532 article-title: Hereditary angioedema treatments: recommendations from the French national center for angioedema (Bordeaux consensus 2014) publication-title: Presse Med – volume: 50 start-page: 567 issue: 4 year: 2016 end-page: 580 e561 article-title: Efficacy of different medical therapies for the treatment of acute laryngeal attacks of hereditary angioedema due to C1‐esterase inhibitor deficiency publication-title: J Emerg Med – volume: 157 start-page: 417 issue: 4 year: 2012 end-page: 424 article-title: Safety and efficacy of physician‐supervised self‐managed c1 inhibitor replacement therapy publication-title: Int Arch Allergy Immunol – volume: 75 start-page: 2989 issue: 11 year: 2020 end-page: 2992 article-title: A myoferlin gain‐of‐function variant associates with a new type of hereditary angioedema publication-title: Allergy – volume: 70 start-page: 1196 issue: 10 year: 2015 end-page: 1200 article-title: Angioedema induced by cardiovascular drugs: new players join old friends publication-title: Allergy – volume: 8 start-page: 1875 issue: 6 year: 2020 end-page: 1880. e1873 article-title: Experience with intravenous plasma‐derived C1‐inhibitor in pregnant women with hereditary angioedema: a systematic literature review publication-title: J Allergy Clin Immunol Pract – volume: 75 start-page: 349 issue: 4 year: 2000 end-page: 354 article-title: Asphyxiation by laryngeal edema in patients with hereditary angioedema publication-title: Mayo Clin Proc – volume: 15 start-page: 13 year: 2019 article-title: Indirect comparison of intravenous vs. subcutaneous C1‐inhibitor placebo‐controlled trials for routine prevention of hereditary angioedema attacks publication-title: Allergy Asthma Clin Immunol – volume: 99 start-page: 212 issue: 3 year: 1992 end-page: 215 article-title: The effects of fetal exposure to danazol publication-title: Br J Obstet Gynaecol – volume: 16 start-page: 173 issue: 3 year: 2007 end-page: 176 article-title: Intracranial hypertension associated with danazol withdrawal: a case report publication-title: Acta Neurol Taiwan – volume: 57 start-page: 751 issue: 5 year: 2018 end-page: 755 article-title: Comparison of the frequency of angioedema attack, before and during pregnancy, in a patient with type I hereditary angioedema publication-title: Intern Med – volume: 3 start-page: 193 year: 1965 end-page: 201 article-title: Peripheral arteriography during Bradykinin induced vasodilation publication-title: Acta Radiol Diagn (Stockh) – volume: 320 start-page: 2108 issue: 20 year: 2018 end-page: 2121 article-title: Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial publication-title: JAMA – volume: 74 start-page: 2479 issue: 12 year: 2019 end-page: 2481 article-title: Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykinin publication-title: Allergy – volume: 1 start-page: 39 year: 1972 end-page: 52 article-title: Acquired C1 inhibitor deficiency in lymphosarcoma publication-title: Clin Immunol Immunopathol – volume: 120 start-page: e713 issue: 3 year: 2007 end-page: e722 article-title: Management of hereditary angioedema in pediatric patients publication-title: Pediatrics – volume: 114 start-page: 629 issue: 3 year: 2004 end-page: 637 article-title: Canadian 2003 International consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema publication-title: J Allergy Clin Immunol – volume: 148 start-page: 1526 issue: 6 year: 2021 end-page: 1532 article-title: Consensus on treatment goals in hereditary angioedema: a global Delphi initiative publication-title: J Allergy Clin Immunol – volume: 35 start-page: 117 issue: 3 year: 2007 end-page: 119 article-title: A successful pregnancy and uncomplicated labor with C1INH concentrate prophylaxis in a patient with hereditary angioedema publication-title: Allergol Immunopathol (Madr) – volume: 35 start-page: 371 issue: 5 year: 2014 end-page: 376 article-title: Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks publication-title: Allergy Asthma Proc – volume: 32 start-page: 909 issue: 5 year: 2010 end-page: 914 article-title: Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis publication-title: Clin Ther – volume: 41 start-page: 366 issue: 4 year: 2016 end-page: 371 article-title: An analysis of the teaching of intravenous self‐administration in patients with hereditary angio‐oedema publication-title: Clin Exp Dermatol – volume: 13 start-page: 51 issue: 1 year: 2018 article-title: Safety, effectiveness, and impact on quality of life of self‐administration with plasma‐derived nanofiltered C1 inhibitor (Berinert(R)) in patients with hereditary angioedema: the SABHA study publication-title: Orphanet J Rare Dis – volume: 5 start-page: 182 issue: 12 year: 2012 end-page: 199 article-title: WAO guideline for the management of hereditary angioedema publication-title: World Allergy Organ J – volume: 57 start-page: 404 issue: 4 year: 1999 end-page: 408 article-title: The efficacy of short‐term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures publication-title: J Oral Maxillofac Surg – volume: 19 start-page: 978 issue: 10 year: 2020 end-page: 983 article-title: Prospective analysis in patients with HAE under prophylaxis with lanadelumab: a real‐life experience publication-title: J Drugs Dermatol – volume: 29 start-page: 225 issue: 3 year: 2008 end-page: 231 article-title: Appraisal of danazol prophylaxis for hereditary angioedema publication-title: Allergy Asthma Proc – volume: 363 start-page: 523 issue: 6 year: 2010 end-page: 531 article-title: Ecallantide for the treatment of acute attacks in hereditary angioedema publication-title: N Engl J Med – volume: 62 start-page: 107 issue: 1 year: 2017 end-page: 110 article-title: Hereditary angioedema: death after a dental extraction publication-title: Aust Dent J – volume: 124 start-page: 600 issue: 6 year: 2020 end-page: 607 article-title: Patient‐reported burden of hereditary angioedema: findings from a patient survey in the United States publication-title: Ann Allergy Asthma Immunol – volume: 61 start-page: 40 issue: 1 year: 2021 end-page: 49 article-title: Differences and similarities in the mechanisms and clinical expression of Bradykinin‐mediated vs. mast cell‐mediated angioedema publication-title: Clin Rev Allergy Immunol – volume: 38 start-page: 143 issue: 2 year: 2017 end-page: 151 article-title: Health‐related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1‐inhibitor with recombinant hyaluronidase publication-title: Allergy Asthma Proc – volume: 20 start-page: 587 issue: 4 year: 2019 end-page: 600 article-title: Evaluation and management of angioedema in the emergency department publication-title: West J Emerg Med – volume: 41 start-page: S03 issue: Suppl 1 year: 2020 end-page: S07 article-title: Definition and classification of hereditary angioedema publication-title: Allergy Asthma Proc – volume: 75 start-page: 1394 issue: 6 year: 2020 end-page: 1403 article-title: Impaired control of the contact system in hereditary angioedema with normal C1‐inhibitor publication-title: Allergy – volume: 15 start-page: 49 year: 2019 article-title: Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo‐controlled randomized study publication-title: Allergy Asthma Clin Immunol – volume: 41 start-page: 541 issue: 7 year: 1996 end-page: 544 article-title: Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report publication-title: J Reprod Med – volume: 13 start-page: 31 year: 2017 article-title: Breakthrough attacks in patients with hereditary angioedema receiving long‐term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey publication-title: Allergy Asthma Clin Immunol – volume: 43 start-page: 475 issue: 4 year: 2013 end-page: 482 article-title: Benefits of progestin contraception in non‐allergic angioedema publication-title: Clin Exp Allergy – volume: 351 start-page: 1693 issue: 9117 year: 1998 end-page: 1697 article-title: Plasma bradykinin in angio‐oedema publication-title: Lancet – ident: e_1_2_17_196_1 doi: 10.1001/jama.2018.16773 – ident: e_1_2_17_268_1 doi: 10.1111/j.1398-9995.2011.02751.x – ident: e_1_2_17_133_1 doi: 10.1056/NEJM199606203342503 – ident: e_1_2_17_331_1 doi: 10.2500/ar.2017.8.0210 – ident: e_1_2_17_46_1 doi: 10.1111/j.1365-2133.2009.09366.x – ident: e_1_2_17_147_1 doi: 10.1016/j.jbiotec.2012.09.005 – ident: e_1_2_17_120_1 – ident: e_1_2_17_101_1 doi: 10.1111/j.1572-0241.2006.00492.x – ident: e_1_2_17_41_1 doi: 10.1016/0090-1229(72)90006-2 – ident: e_1_2_17_236_1 doi: 10.1056/NEJMoa1605767 – ident: e_1_2_17_129_1 doi: 10.1016/j.waojou.2019.100049 – ident: e_1_2_17_276_1 doi: 10.1016/j.jaci.2011.11.025 – ident: e_1_2_17_131_1 doi: 10.1111/j.1398-9995.2010.02433.x – ident: e_1_2_17_292_1 doi: 10.1016/j.jaci.2012.12.789 – ident: e_1_2_17_87_1 doi: 10.1111/all.13397 – ident: e_1_2_17_354_1 doi: 10.1016/j.iac.2017.04.007 – ident: e_1_2_17_139_1 doi: 10.1016/j.clim.2011.11.005 – ident: e_1_2_17_256_1 doi: 10.1016/0091-6749(81)90181-0 – ident: e_1_2_17_119_1 – ident: e_1_2_17_296_1 doi: 10.1016/j.aller.2012.01.002 – ident: e_1_2_17_281_1 doi: 10.1155/2019/9157895 – ident: e_1_2_17_81_1 doi: 10.1186/s13023-019-1043-3 – ident: e_1_2_17_207_1 doi: 10.1016/j.jaip.2021.03.057 – ident: e_1_2_17_324_1 doi: 10.1055/s-0038-1647471 – ident: e_1_2_17_64_1 doi: 10.1186/s13023-020-1334-8 – ident: e_1_2_17_95_1 doi: 10.5152/tao.2020.5994 – ident: e_1_2_17_123_1 doi: 10.1016/j.jaci.2009.07.017 – ident: e_1_2_17_62_1 doi: 10.1016/j.molimm.2019.06.017 – ident: e_1_2_17_180_1 doi: 10.1177/0091217419837068 – volume: 41 start-page: S08 issue: 1 year: 2020 ident: e_1_2_17_49_1 article-title: Hereditary angioedema: epidemiology and burden of disease publication-title: Allergy Asthma Proc doi: 10.2500/aap.2020.41.200050 – ident: e_1_2_17_367_1 doi: 10.2500/aap.2015.36.3820 – ident: e_1_2_17_18_1 doi: 10.1016/j.amjmed.2005.09.064 – ident: e_1_2_17_372_1 doi: 10.1159/000351236 – ident: e_1_2_17_347_1 doi: 10.1016/j.jaip.2013.07.002 – ident: e_1_2_17_344_1 doi: 10.1016/j.iac.2013.07.003 – ident: e_1_2_17_219_1 doi: 10.1111/pai.12364 – ident: e_1_2_17_387_1 doi: 10.2500/aap.2020.41.200042 – ident: e_1_2_17_14_1 doi: 10.1111/j.1398-9995.2010.02530.x – ident: e_1_2_17_51_1 doi: 10.1002/humu.23917 – ident: e_1_2_17_197_1 doi: 10.1016/j.jaip.2021.04.072 – ident: e_1_2_17_75_1 doi: 10.1007/s00105-018-4318-z – ident: e_1_2_17_143_1 doi: 10.1016/j.biologicals.2006.08.005 – volume: 97 start-page: A‐1016 issue: 15 year: 2000 ident: e_1_2_17_229_1 article-title: Schwerwiegende thrombenbildung nach Berinert® HS publication-title: Deutsches Ärzteblatt – volume: 41 start-page: 541 issue: 7 year: 1996 ident: e_1_2_17_334_1 article-title: Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report publication-title: J Reprod Med – ident: e_1_2_17_336_1 doi: 10.1157/13106781 – ident: e_1_2_17_93_1 doi: 10.1159/000439032 – ident: e_1_2_17_159_1 doi: 10.1080/17512433.2016.1182425 – ident: e_1_2_17_59_1 doi: 10.1007/BF00168965 – ident: e_1_2_17_208_1 doi: 10.1016/j.jaci.2020.10.015 – ident: e_1_2_17_275_1 doi: 10.1056/NEJM197301042880123 – ident: e_1_2_17_225_1 doi: 10.1186/s13223-019-0328-3 – ident: e_1_2_17_315_1 doi: 10.1111/cea.12055 – ident: e_1_2_17_103_1 doi: 10.2500/aap.2015.36.3831 – ident: e_1_2_17_242_1 – volume: 3 start-page: 733 issue: 7 year: 1968 ident: e_1_2_17_271_1 article-title: A case of hereditary angioneurotic oedema, successfully treated with epsilon‐aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism publication-title: Clin Exp Immunol – ident: e_1_2_17_77_1 doi: 10.26442/00403660.2020.12.200447 – ident: e_1_2_17_88_1 doi: 10.2340/00015555-2233 – ident: e_1_2_17_192_1 doi: 10.1111/all.12007 – ident: e_1_2_17_114_1 doi: 10.1007/s12016-021-08839-4 – ident: e_1_2_17_257_1 doi: 10.1186/s13023-014-0205-6 – ident: e_1_2_17_233_1 doi: 10.1016/j.jaip.2016.04.018 – ident: e_1_2_17_382_1 doi: 10.2500/aap.2021.42.210066 – ident: e_1_2_17_252_1 doi: 10.1007/s00228-009-0771-z – ident: e_1_2_17_125_1 doi: 10.1016/j.anai.2013.12.004 – ident: e_1_2_17_312_1 doi: 10.1007/s00431-012-1726-4 – ident: e_1_2_17_212_1 doi: 10.1111/j.1610-0387.2010.07546_suppl.x – ident: e_1_2_17_45_1 doi: 10.1016/j.jaip.2016.12.032 – ident: e_1_2_17_61_1 doi: 10.1007/BF00164878 – ident: e_1_2_17_76_1 doi: 10.3390/jcm9113402 – ident: e_1_2_17_67_1 doi: 10.1136/jcp.2003.12021 – ident: e_1_2_17_145_1 doi: 10.1111/bcp.12132 – ident: e_1_2_17_310_1 doi: 10.1016/j.jaci.2012.08.036 – ident: e_1_2_17_92_1 doi: 10.1016/j.jaci.2014.02.036 – ident: e_1_2_17_241_1 doi: 10.1056/NEJMoa1716995 – ident: e_1_2_17_358_1 doi: 10.31744/einstein_journal/2021RW5498 – ident: e_1_2_17_5_1 doi: 10.1111/all.13384 – ident: e_1_2_17_228_1 doi: 10.1016/j.anai.2016.03.008 – ident: e_1_2_17_329_1 doi: 10.1186/s13256-020-02622-3 – ident: e_1_2_17_80_1 doi: 10.1097/MD.0000000000004363 – ident: e_1_2_17_96_1 doi: 10.5604/01.3001.0014.0619 – ident: e_1_2_17_84_1 doi: 10.1016/S1081-1206(10)60369-9 – volume: 192 start-page: 293 issue: 4 year: 1972 ident: e_1_2_17_273_1 article-title: Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double‐blind cross‐over study publication-title: Acta Med Scand doi: 10.1111/j.0954-6820.1972.tb04818.x – ident: e_1_2_17_325_1 doi: 10.1016/0049-3848(81)90206-1 – ident: e_1_2_17_31_1 doi: 10.1016/S0140-6736(00)02483-1 – ident: e_1_2_17_205_1 doi: 10.1111/all.15011 – ident: e_1_2_17_178_1 doi: 10.1016/j.jaip.2020.08.046 – ident: e_1_2_17_142_1 doi: 10.2500/aap.2020.41.190021 – ident: e_1_2_17_267_1 doi: 10.1016/S0168-8278(02)00035-1 – ident: e_1_2_17_285_1 doi: 10.1111/all.13466 – ident: e_1_2_17_374_1 doi: 10.2500/aap.2010.31.3403 – ident: e_1_2_17_379_1 doi: 10.1111/j.1523-5378.2007.00501.x – ident: e_1_2_17_262_1 doi: 10.1016/j.clinthera.2010.04.017 – ident: e_1_2_17_349_1 doi: 10.2500/aap.2015.36.3824 – ident: e_1_2_17_342_1 doi: 10.3389/fmed.2017.00245 – ident: e_1_2_17_204_1 doi: 10.1186/s13223-017-0203-z – ident: e_1_2_17_265_1 doi: 10.7326/0003-4819-86-3-306 – ident: e_1_2_17_323_1 doi: 10.2147/IJWH.S46460 – ident: e_1_2_17_8_1 doi: 10.1016/S1081-1206(10)60584-4 – ident: e_1_2_17_295_1 doi: 10.1111/j.1399-3038.2005.00275.x – ident: e_1_2_17_48_1 doi: 10.1186/s13023-018-0815-5 – ident: e_1_2_17_118_1 – ident: e_1_2_17_319_1 doi: 10.1016/j.ajog.2010.03.003 – ident: e_1_2_17_174_1 doi: 10.2500/aap.2021.42.210006 – ident: e_1_2_17_266_1 doi: 10.1016/S0140-6736(99)00110-5 – ident: e_1_2_17_313_1 doi: 10.18176/jiaci.0102 – ident: e_1_2_17_172_1 doi: 10.1016/j.jaip.2019.08.011 – ident: e_1_2_17_220_1 doi: 10.1111/pai.12495 – ident: e_1_2_17_22_1 doi: 10.2500/ajra.2011.25.3661 – ident: e_1_2_17_107_1 doi: 10.1016/j.anai.2012.12.007 – ident: e_1_2_17_232_1 doi: 10.2500/aap.2013.34.3702 – ident: e_1_2_17_121_1 – ident: e_1_2_17_210_1 doi: 10.1016/j.iac.2013.07.005 – ident: e_1_2_17_7_1 doi: 10.1016/j.jaci.2004.06.043 – ident: e_1_2_17_65_1 doi: 10.1016/j.iac.2013.07.001 – ident: e_1_2_17_15_1 doi: 10.1007/s12016-021-08854-5 – ident: e_1_2_17_79_1 doi: 10.1016/j.revmed.2020.06.010 – ident: e_1_2_17_320_1 doi: 10.18176/jiaci.0037 – ident: e_1_2_17_181_1 doi: 10.1111/all.14680 – ident: e_1_2_17_215_1 doi: 10.1016/j.jpeds.2012.11.030 – ident: e_1_2_17_277_1 doi: 10.1034/j.1399-3038.2002.01014.x – ident: e_1_2_17_126_1 doi: 10.1016/j.jaci.2010.07.021 – ident: e_1_2_17_371_1 doi: 10.2500/aap.2014.35.3753 – ident: e_1_2_17_104_1 doi: 10.1111/all.12731 – ident: e_1_2_17_355_1 doi: 10.1111/cei.12083 – ident: e_1_2_17_302_1 doi: 10.1203/00006450-199402000-00012 – ident: e_1_2_17_272_1 doi: 10.1136/adc.49.8.636 – volume: 21 start-page: 422 issue: 6 year: 2011 ident: e_1_2_17_12_1 article-title: Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow‐up, and special situations publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_17_72_1 doi: 10.1016/j.jpba.2020.113844 – ident: e_1_2_17_238_1 doi: 10.1111/all.14416 – ident: e_1_2_17_234_1 doi: 10.1080/17512433.2020.1776110 – ident: e_1_2_17_124_1 doi: 10.1016/j.anai.2010.04.012 – ident: e_1_2_17_69_1 doi: 10.1016/j.jim.2008.06.004 – ident: e_1_2_17_314_1 doi: 10.1016/j.ajog.2008.04.034 – ident: e_1_2_17_317_1 doi: 10.1542/peds.2006-3303 – ident: e_1_2_17_327_1 doi: 10.2500/aap.2017.38.4038 – volume-title: Ueber acutes Oedem year: 1882 ident: e_1_2_17_20_1 – ident: e_1_2_17_165_1 doi: 10.14219/jada.archive.2003.0323 – ident: e_1_2_17_173_1 doi: 10.1186/1749-8090-5-86 – ident: e_1_2_17_167_1 doi: 10.1111/all.12032 – ident: e_1_2_17_226_1 doi: 10.1177/0897190019857407 – ident: e_1_2_17_106_1 doi: 10.1007/s10875-010-9442-1 – ident: e_1_2_17_54_1 doi: 10.1186/s12948-021-00141-0 – ident: e_1_2_17_83_1 doi: 10.1111/all.12680 – ident: e_1_2_17_86_1 doi: 10.1007/s00011-013-0693-1 – ident: e_1_2_17_137_1 doi: 10.1111/j.1537-2995.2009.02394.x – ident: e_1_2_17_388_1 doi: 10.2500/aap.2019.40.4213 – ident: e_1_2_17_135_1 doi: 10.1016/j.anai.2010.06.005 – ident: e_1_2_17_82_1 doi: 10.1016/j.jaip.2020.08.052 – ident: e_1_2_17_164_1 doi: 10.1111/all.12186 – ident: e_1_2_17_38_1 doi: 10.1186/s13023-020-01570-x – ident: e_1_2_17_360_1 doi: 10.1007/s00063-018-0483-1 – ident: e_1_2_17_169_1 doi: 10.1016/j.anai.2014.05.009 – ident: e_1_2_17_326_1 doi: 10.2500/aap.2013.34.3645 – volume-title: Global Forum on Hereditary Angioedema, Warsaw, Poland year: 2016 ident: e_1_2_17_289_1 – ident: e_1_2_17_318_1 doi: 10.1016/j.ejogrb.2010.05.008 – ident: e_1_2_17_24_1 doi: 10.1016/j.jaad.2004.09.032 – ident: e_1_2_17_162_1 doi: 10.4065/75.4.349 – ident: e_1_2_17_4_1 doi: 10.1016/S0140-6736(97)09137-X – ident: e_1_2_17_128_1 doi: 10.1111/j.1742-1241.2005.00352.x – ident: e_1_2_17_248_1 doi: 10.1186/s13023-021-01717-4 – ident: e_1_2_17_29_1 doi: 10.1016/j.jaip.2018.04.022 – ident: e_1_2_17_200_1 doi: 10.1007/s12016-018-8684-1 – ident: e_1_2_17_111_1 doi: 10.1371/journal.pone.0053773 – ident: e_1_2_17_132_1 doi: 10.1046/j.1537-2995.1998.38698326333.x – volume: 2018 year: 2018 ident: e_1_2_17_97_1 article-title: Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian registry publication-title: Case Rep Emerg Med – ident: e_1_2_17_190_1 doi: 10.1111/all.14144 – ident: e_1_2_17_261_1 doi: 10.1016/j.anai.2015.01.003 – ident: e_1_2_17_218_1 doi: 10.1016/j.jaip.2013.09.008 – ident: e_1_2_17_78_1 doi: 10.1111/joim.13182 – ident: e_1_2_17_283_1 doi: 10.3389/fmed.2017.00212 – ident: e_1_2_17_171_1 doi: 10.1016/j.anai.2016.10.006 – ident: e_1_2_17_71_1 doi: 10.1007/s10875-015-0222-9 – ident: e_1_2_17_249_1 doi: 10.1016/0091-6749(80)90181-5 – ident: e_1_2_17_284_1 doi: 10.2500/aap.2017.38.4087 – ident: e_1_2_17_183_1 doi: 10.1186/s13023-020-01658-4 – ident: e_1_2_17_56_1 doi: 10.1007/s12016-021-08837-6 – ident: e_1_2_17_148_1 doi: 10.2217/imt.15.44 – ident: e_1_2_17_153_1 doi: 10.1016/j.jaip.2014.09.001 – ident: e_1_2_17_356_1 doi: 10.1097/PEC.0000000000002402 – ident: e_1_2_17_291_1 doi: 10.1177/0009922815616886 – ident: e_1_2_17_339_1 doi: 10.1016/j.lpm.2015.01.005 – ident: e_1_2_17_163_1 doi: 10.1016/j.anai.2015.04.005 – ident: e_1_2_17_340_1 doi: 10.1089/bfm.2014.0027 – ident: e_1_2_17_89_1 doi: 10.1016/j.anai.2019.02.019 – ident: e_1_2_17_301_1 doi: 10.1186/s13023-017-0604-6 – ident: e_1_2_17_350_1 doi: 10.1016/j.lpm.2014.06.030 – ident: e_1_2_17_112_1 doi: 10.1159/000430864 – ident: e_1_2_17_73_1 doi: 10.1016/j.jaip.2019.10.004 – ident: e_1_2_17_117_1 – ident: e_1_2_17_247_1 doi: 10.2500/aap.2021.42.200127 – ident: e_1_2_17_386_1 doi: 10.1159/000512944 – volume: 126 start-page: 76 issue: 1 year: 2016 ident: e_1_2_17_28_1 article-title: Bradykinin‐mediated angioedema publication-title: Pol Arch Med Wewn doi: 10.20452/pamw.3273 – ident: e_1_2_17_90_1 doi: 10.2340/00015555-2350 – ident: e_1_2_17_369_1 doi: 10.2147/PPA.S86379 – ident: e_1_2_17_144_1 doi: 10.1111/pai.13065 – volume: 5 start-page: 38 issue: 3 year: 1977 ident: e_1_2_17_250_1 article-title: Danazol in the treatment of hereditary angio‐neurotic oedema publication-title: J Int Med Res – ident: e_1_2_17_348_1 doi: 10.2500/ar.2016.7.0165 – ident: e_1_2_17_353_1 doi: 10.1186/1710-1492-6-21 – ident: e_1_2_17_380_1 doi: 10.1111/all.13034 – ident: e_1_2_17_50_1 doi: 10.1007/s12016-016-8543-x – ident: e_1_2_17_160_1 doi: 10.1080/1744666X.2018.1476851 – ident: e_1_2_17_34_1 doi: 10.1111/all.13270 – ident: e_1_2_17_30_1 doi: 10.1016/j.therap.2020.02.011 – ident: e_1_2_17_198_1 doi: 10.1016/j.jaip.2019.01.054 – ident: e_1_2_17_122_1 doi: 10.1056/NEJMoa0906393 – ident: e_1_2_17_194_1 doi: 10.1111/all.12900 – ident: e_1_2_17_105_1 doi: 10.1001/archinte.161.5.714 – ident: e_1_2_17_343_1 doi: 10.2500/aap.2020.41.200059 – ident: e_1_2_17_365_1 doi: 10.1111/all.12303 – ident: e_1_2_17_151_1 – ident: e_1_2_17_201_1 doi: 10.1186/s13223-019-0362-1 – ident: e_1_2_17_9_1 doi: 10.1186/1710-1492-6-24 – ident: e_1_2_17_27_1 doi: 10.1016/j.waojou.2021.100554 – ident: e_1_2_17_330_1 doi: 10.1016/j.jaip.2019.05.042 – ident: e_1_2_17_35_1 doi: 10.1111/all.13869 – ident: e_1_2_17_66_1 doi: 10.5114/ada.2020.98226 – ident: e_1_2_17_94_1 doi: 10.23822/EurAnnACI.1764-1489.204 – ident: e_1_2_17_21_1 doi: 10.1056/NEJM196906122802414 – ident: e_1_2_17_68_1 doi: 10.1111/j.1365-2249.2007.03438.x – ident: e_1_2_17_158_1 doi: 10.1016/j.jaci.2007.02.012 – ident: e_1_2_17_47_1 doi: 10.1186/s13023-015-0233-x – ident: e_1_2_17_300_1 doi: 10.1111/pai.13309 – ident: e_1_2_17_216_1 doi: 10.1016/j.jaip.2019.01.021 – ident: e_1_2_17_264_1 doi: 10.2500/aap.2008.29.3107 – ident: e_1_2_17_311_1 doi: 10.1016/j.jaci.2012.08.001 – ident: e_1_2_17_3_1 doi: 10.1016/0002-9343(63)90162-1 – ident: e_1_2_17_269_1 doi: 10.1210/er.2001-0014 – ident: e_1_2_17_306_1 doi: 10.1016/j.jaci.2014.08.007 – volume: 156 start-page: 183 year: 1983 ident: e_1_2_17_58_1 article-title: Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma publication-title: Adv Exp Med Biol – ident: e_1_2_17_377_1 doi: 10.1186/s13023-018-0832-4 – ident: e_1_2_17_214_1 doi: 10.1111/pai.13060 – ident: e_1_2_17_40_1 doi: 10.1159/000512933 – ident: e_1_2_17_381_1 doi: 10.1111/cea.13870 – ident: e_1_2_17_213_1 doi: 10.1186/1710-1492-10-50 – ident: e_1_2_17_16_1 doi: 10.1016/S0016‐3287(69)80025‐X – ident: e_1_2_17_298_1 doi: 10.1111/all.13001 – ident: e_1_2_17_175_1 doi: 10.1186/1710-1492-6-13 – ident: e_1_2_17_193_1 doi: 10.1111/all.12209 – volume: 8 start-page: 212605 year: 2019 ident: e_1_2_17_203_1 article-title: Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research publication-title: Drugs Context – ident: e_1_2_17_57_1 doi: 10.1111/jth.14209 – ident: e_1_2_17_328_1 doi: 10.1016/j.jaip.2020.03.009 – ident: e_1_2_17_185_1 doi: 10.2340/00015555-3807 – ident: e_1_2_17_176_1 doi: 10.1111/j.1365-2249.2005.02726.x – volume: 112 start-page: 418 issue: 5 year: 2020 ident: e_1_2_17_100_1 article-title: Ultrasound findings in an abdominal crisis of a patient with hereditary angioedema publication-title: Rev Esp Enferm Dig – ident: e_1_2_17_155_1 doi: 10.1177/028418516500300301 – ident: e_1_2_17_116_1 doi: 10.1007/s12325-012-0053-5 – volume: 25 start-page: 447 issue: 6 year: 2015 ident: e_1_2_17_333_1 article-title: Icatibant exposure during pregnancy in a patient with hereditary angioedema publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_17_32_1 doi: 10.1016/j.bbrc.2006.03.092 – ident: e_1_2_17_239_1 – ident: e_1_2_17_230_1 doi: 10.2500/aap.2014.35.3799 – ident: e_1_2_17_346_1 doi: 10.1016/j.transci.2003.08.008 – ident: e_1_2_17_368_1 doi: 10.2340/00015555-1743 – ident: e_1_2_17_274_1 doi: 10.1056/NEJM197208312870907 – ident: e_1_2_17_36_1 doi: 10.1111/all.14454 – ident: e_1_2_17_316_1 doi: 10.1186/1750-1172-9-44 – ident: e_1_2_17_259_1 doi: 10.1111/j.1471-0528.1992.tb14501.x – ident: e_1_2_17_55_1 doi: 10.1007/s12016-016-8555-6 – ident: e_1_2_17_91_1 doi: 10.1111/all.13878 – volume: 12 issue: 8 year: 2020 ident: e_1_2_17_130_1 article-title: Novel use of Fresh Frozen plasma in treating hereditary angioedema: a success story from Pakistan publication-title: Cureus – ident: e_1_2_17_146_1 doi: 10.1016/j.jaci.2005.05.019 – ident: e_1_2_17_37_1 doi: 10.1016/j.jaci.2021.01.011 – ident: e_1_2_17_352_1 doi: 10.1007/s00108-019-0644-1 – ident: e_1_2_17_202_1 doi: 10.1159/000514973 – ident: e_1_2_17_157_1 doi: 10.2500/aap.2015.36.3892 – ident: e_1_2_17_184_1 doi: 10.2500/aap.2014.35.3783 – ident: e_1_2_17_33_1 doi: 10.1016/j.jaci.2017.05.020 – ident: e_1_2_17_110_1 doi: 10.1016/j.anai.2013.06.021 – ident: e_1_2_17_109_1 doi: 10.1111/j.1398-9995.2011.02702.x – ident: e_1_2_17_370_1 doi: 10.1159/000329635 – ident: e_1_2_17_308_1 doi: 10.1016/j.jaip.2017.04.010 – ident: e_1_2_17_44_1 doi: 10.1155/2017/1476402 – ident: e_1_2_17_227_1 doi: 10.1016/j.anai.2018.07.025 – ident: e_1_2_17_366_1 doi: 10.1111/j.1537-2995.2011.03240.x – ident: e_1_2_17_253_1 doi: 10.1056/NEJM197612232952602 – ident: e_1_2_17_376_1 doi: 10.2500/aap.2020.41.200058 – ident: e_1_2_17_321_1 doi: 10.2169/internalmedicine.9407-17 – ident: e_1_2_17_297_1 doi: 10.1186/1710-1492-6-18 – ident: e_1_2_17_187_1 doi: 10.18176/jiaci.0479 – ident: e_1_2_17_240_1 doi: 10.1111/all.14670 – ident: e_1_2_17_245_1 doi: 10.2147/JAA.S284029 – ident: e_1_2_17_108_1 doi: 10.2500/aap.2011.32.3440 – ident: e_1_2_17_52_1 doi: 10.1067/mai.2000.110471 – ident: e_1_2_17_255_1 doi: 10.1111/j.1537-2995.2009.02230.x – ident: e_1_2_17_364_1 doi: 10.1186/s13023-018-0797-3 – ident: e_1_2_17_43_1 doi: 10.1111/jch.13097 – volume: 41 start-page: S03 issue: 1 year: 2020 ident: e_1_2_17_53_1 article-title: Definition and classification of hereditary angioedema publication-title: Allergy Asthma Proc doi: 10.2500/aap.2020.41.200040 – ident: e_1_2_17_13_1 doi: 10.1590/S1807-59322011000900021 – ident: e_1_2_17_231_1 doi: 10.2500/aap.2016.37.3933 – ident: e_1_2_17_260_1 doi: 10.7326/0003-4819-96-5-672 – ident: e_1_2_17_332_1 doi: 10.1111/jog.13003 – ident: e_1_2_17_278_1 doi: 10.1016/j.jaip.2021.02.026 – ident: e_1_2_17_362_1 doi: 10.1159/000351232 – ident: e_1_2_17_42_1 doi: 10.1046/j.1365-2133.1997.d01-1160.x – ident: e_1_2_17_168_1 doi: 10.1111/adj.12447 – ident: e_1_2_17_217_1 doi: 10.1111/all.12658 – ident: e_1_2_17_299_1 doi: 10.1542/peds.2016-0575 – ident: e_1_2_17_341_1 doi: 10.2147/JAA.S200900 – ident: e_1_2_17_156_1 doi: 10.1152/ajplegacy.1949.156.2.261 – ident: e_1_2_17_99_1 doi: 10.1007/s12016-021-08852-7 – ident: e_1_2_17_39_1 doi: 10.1016/j.iac.2017.04.004 – ident: e_1_2_17_98_1 doi: 10.1016/j.jaci.2012.05.055 – ident: e_1_2_17_338_1 doi: 10.1016/j.ejogrb.2012.07.010 – ident: e_1_2_17_251_1 doi: 10.1016/S1081-1206(10)60424-3 – ident: e_1_2_17_280_1 doi: 10.1186/s13223-021-00537-2 – ident: e_1_2_17_279_1 doi: 10.1007/s12016-021-08850-9 – ident: e_1_2_17_357_1 doi: 10.1111/all.14293 – ident: e_1_2_17_199_1 doi: 10.36849/JDD.2020.5269 – ident: e_1_2_17_26_1 doi: 10.1186/s13601-015-0049-8 – ident: e_1_2_17_254_1 doi: 10.1111/j.1365-2362.2010.02402.x – volume: 16 start-page: 173 issue: 3 year: 2007 ident: e_1_2_17_270_1 article-title: Intracranial hypertension associated with danazol withdrawal: a case report publication-title: Acta Neurol Taiwan – ident: e_1_2_17_244_1 doi: 10.1002/clt2.12035 – ident: e_1_2_17_2_1 doi: 10.1126/science.148.3672.957 – ident: e_1_2_17_363_1 doi: 10.1111/ced.12806 – ident: e_1_2_17_166_1 doi: 10.1016/j.tripleo.2011.02.034 – ident: e_1_2_17_195_1 doi: 10.1016/j.anai.2020.02.018 – ident: e_1_2_17_246_1 doi: 10.1080/1744666X.2018.1503055 – ident: e_1_2_17_263_1 doi: 10.2500/aap.2021.42.200106 – ident: e_1_2_17_290_1 doi: 10.1001/archinte.163.10.1229 – ident: e_1_2_17_188_1 doi: 10.1186/1477-7525-10-82 – ident: e_1_2_17_309_1 doi: 10.1111/pai.12444 – ident: e_1_2_17_186_1 doi: 10.1016/j.iac.2017.04.005 – ident: e_1_2_17_385_1 doi: 10.1016/j.jaip.2021.08.039 – ident: e_1_2_17_141_1 doi: 10.1111/j.1537-2995.2012.03590.x – ident: e_1_2_17_170_1 doi: 10.1016/S0278-2391(99)90280-X – volume: 21 start-page: 333 issue: 5 year: 2011 ident: e_1_2_17_11_1 article-title: Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_17_384_1 doi: 10.18176/jiaci.0701 – ident: e_1_2_17_17_1 doi: 10.1016/j.jclinepi.2013.12.002 – ident: e_1_2_17_113_1 doi: 10.1007/s12016-021-08843-8 – ident: e_1_2_17_361_1 doi: 10.5811/westjem.2019.5.42650 – ident: e_1_2_17_150_1 doi: 10.1007/s40261-015-0300-z – ident: e_1_2_17_383_1 doi: 10.1016/j.jaip.2020.11.042 – ident: e_1_2_17_19_1 doi: 10.1097/00000441-198207000-00001 – volume: 14 start-page: 266 issue: 3 year: 2016 ident: e_1_2_17_211_1 article-title: Prophylaxis in hereditary angioedema (HAE) with C1 inhibitor deficiency publication-title: J Dtsch Dermatol Ges doi: 10.1111/ddg.12856 – ident: e_1_2_17_182_1 doi: 10.1016/j.revmed.2021.05.013 – ident: e_1_2_17_149_1 doi: 10.1111/j.1365-2222.2012.03984.x – ident: e_1_2_17_373_1 doi: 10.1016/j.anai.2010.01.024 – ident: e_1_2_17_10_1 doi: 10.1186/1710-1492-6-22 – volume: 25 start-page: 12 issue: 1 year: 1974 ident: e_1_2_17_134_1 article-title: Hereditary Quincke's edema. New therapeutic ways publication-title: Hautarzt – ident: e_1_2_17_288_1 doi: 10.1186/s13023-016-0518-8 – volume: 69 start-page: 192 issue: 3 year: 2020 ident: e_1_2_17_287_1 article-title: Efficacy, pharmacokinetics, pharmacodynamics, and safety of intravenous C1 inhibitor for long‐term prophylaxis and treatment of breakthrough attacks in Japanese subjects with hereditary angioedema: a phase 3 open‐label study publication-title: Arerugi – ident: e_1_2_17_335_1 doi: 10.1007/s00404-006-0183-6 – volume: 81 start-page: 513 issue: 7 year: 1990 ident: e_1_2_17_305_1 article-title: A review on the acquired, allergic or non‐allergic, and the hereditary forms publication-title: Recenti Prog Med – ident: e_1_2_17_60_1 doi: 10.1007/BF00165559 – ident: e_1_2_17_304_1 doi: 10.1111/sji.12154 – ident: e_1_2_17_136_1 doi: 10.1111/trf.12501 – ident: e_1_2_17_74_1 doi: 10.1016/j.jaip.2017.07.002 – ident: e_1_2_17_70_1 doi: 10.1016/j.clinbiochem.2017.04.007 – ident: e_1_2_17_177_1 doi: 10.1186/s13223-019-0376-8 – ident: e_1_2_17_222_1 doi: 10.1016/j.jaip.2017.12.039 – ident: e_1_2_17_140_1 doi: 10.1016/j.transci.2003.08.006 – ident: e_1_2_17_235_1 doi: 10.1016/j.amjmed.2009.02.024 – ident: e_1_2_17_63_1 doi: 10.1111/all.13076 – ident: e_1_2_17_282_1 doi: 10.1186/s12955-019-1229-3 – ident: e_1_2_17_6_1 doi: 10.1186/s40413-017-0180-1 – ident: e_1_2_17_191_1 doi: 10.1016/j.jaip.2020.02.038 – ident: e_1_2_17_345_1 doi: 10.2500/ar.2015.6.0112 – ident: e_1_2_17_307_1 doi: 10.1016/j.molimm.2008.05.007 – volume: 12 issue: 5 year: 2020 ident: e_1_2_17_322_1 article-title: Pregnancy‐induced exacerbation of hereditary angioedema in a multiparous caucasian female publication-title: Cureus – ident: e_1_2_17_161_1 doi: 10.1016/j.jemermed.2015.11.008 – ident: e_1_2_17_258_1 doi: 10.1016/j.iac.2013.07.006 – ident: e_1_2_17_102_1 doi: 10.1016/j.amjmed.2011.12.016 – volume: 64 start-page: 441 issue: 4 year: 2015 ident: e_1_2_17_378_1 article-title: Perioperative management of a patient with hereditary angioedema: a case report publication-title: Masui – ident: e_1_2_17_189_1 doi: 10.1016/j.jaip.2015.12.010 – ident: e_1_2_17_127_1 doi: 10.1056/NEJMoa0805538 – ident: e_1_2_17_25_1 doi: 10.1007/s12016-021-08841-w – ident: e_1_2_17_221_1 doi: 10.1111/ced.12681 – ident: e_1_2_17_115_1 doi: 10.1111/ced.12285 – ident: e_1_2_17_152_1 doi: 10.1056/NEJMoa0905079 – ident: e_1_2_17_237_1 doi: 10.1016/j.anai.2014.05.028 – ident: e_1_2_17_209_1 doi: 10.1097/WOX.0b013e318279affa – ident: e_1_2_17_154_1 doi: 10.1161/01.RES.11.6.910 – ident: e_1_2_17_23_1 doi: 10.1111/all.12380 – ident: e_1_2_17_138_1 doi: 10.1111/j.1365-2222.1975.tb01839.x – ident: e_1_2_17_179_1 doi: 10.1016/j.jaci.2021.05.016 – ident: e_1_2_17_224_1 doi: 10.2500/aap.2017.38.4025 – ident: e_1_2_17_303_1 doi: 10.1016/j.alit.2019.07.005 – ident: e_1_2_17_375_1 doi: 10.1111/pde.12408 – ident: e_1_2_17_359_1 doi: 10.1016/j.jemermed.2020.09.044 – ident: e_1_2_17_243_1 doi: 10.2500/aap.2021.42.210034 – ident: e_1_2_17_286_1 doi: 10.1016/j.jaci.2016.03.043 – ident: e_1_2_17_206_1 doi: 10.1056/NEJMoa1613627 – ident: e_1_2_17_294_1 doi: 10.1016/j.anai.2020.01.009 – ident: e_1_2_17_223_1 doi: 10.1002/ccr3.3743 – ident: e_1_2_17_351_1 doi: 10.1586/1744666X.2016.1100963 – volume: 54 start-page: 365 issue: 3 year: 2008 ident: e_1_2_17_337_1 article-title: Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate publication-title: Can Fam Physician Med Fam Can – ident: e_1_2_17_293_1 doi: 10.1542/peds.2015-2411 – ident: e_1_2_17_85_1 doi: 10.1111/all.14160 |
| SSID | ssj0007290 |
| Score | 2.7210546 |
| Snippet | Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the... Abstract Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of... |
| SourceID | hal proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1961 |
| SubjectTerms | Angioedema Angioedemas, Hereditary - prevention & control Angioedemas, Hereditary - therapy Breast C1 inhibitor Child Clinical decision making Complement C1 Inhibitor Protein - genetics Complement C1 Inhibitor Protein - therapeutic use Complement component C1 Consensus DELPHI Diagnosis disease control Edema Female Genetic disorders guideline hereditary angioedema Humans Inflammatory diseases Life Sciences Management Medical treatment Patients Pregnancy Skin |
| Title | The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.15214 https://www.ncbi.nlm.nih.gov/pubmed/35006617 https://www.proquest.com/docview/2682180114 https://www.proquest.com/docview/2618503492 https://hal.science/hal-04997520 |
| Volume | 77 |
| WOSCitedRecordID | wos000750277200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB5RqKpeKG1pGwrIIA69RGziZG2rp4iyAildEIKyt8h2HFhpya72hzMP0SfskzCTzUYgqITEJX-eJE7s8Xy2x98A7FlOvH-59KNYOz8SLvAVNgl-25qiUMKKomLn_5OKblf2eup0CX4u1sLM-SGaATfSjKq9JgXXZvJAyfVgQMF7KIj1ShBwSXEbwui0aYZFPcCCAAIzwmVNK0RuPM2tj4zRm2tyhXyKMx_D1srudD68KsdrsFrDTZbM68dHWHLlJ3j3u55Q_wwjrCas_3BUkF0mJ_uHSXJwzK5mxIGFcgyRLUOkyG4aZxk2LNg1xfnsTzFDTJdX_aHL3Y3-d_eXnhmiVWfjeuk6JudsNqLBhXW46ByeHxz5dRAG30Zo3n2DJk628lZo2k4HloL4ceyAy0I54TQBntiFseXE8yKMUQjPWjLXgmslucX9F1guh6X7BswqzaNcRYVCsbwIpNam4DrSmhuDbYsHPxalkdmaoZwCZQyyRU8F_2BW_UEPdhvR0ZyW41khLNImnYi0j5I0o2vU0RNx2LoNPNhclHhWq-8kC9sSoQ_1FT3YaZJR8Wg2RZduOCMZhDrE7hN68HVeU5pX8ZigXCDwi6oK8f88ZkmaVgcbLxf9Du9DWoRROQ1vwvJ0PHNb8NbeTvuT8XalBbgVPbkNK7_OOhcpnl0ed-8BxDcLMA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fT9swED_xZwJexgYbZJTNQzzwEtHESW1LvEQVqNVCtwcGvEWO40Clklal5XkfYp-QT8JdmkYgQELiKVF8SS6xz_fz2f4dwL7hxPuXSTcItXUDYT1XYZfgtkya50oYkZfs_Oex6PXk5aX6swBH870wM36IOuBGllH212TgFJB-ZOV6MKDsPZTFejlAoEGJGy66vbofFlWEBREEasJlxStE63jqW594o8VrWgv5HGg-xa2l4zlZf5_Kn-BjBThZNGshn2HBFhuwclpNqW_CCBsK6z-OC7KL6PfhcRS1u-xqSixYKMcQ2zLEiuymXi7Dhjm7pkyf_QlqxHRx1R_azN7o-3__6Zk--nU2rjavY3HGpiMKL3yBvyfHZ-2OW6VhcE2ADt5N0cnJZtb005bVnqE0fhyH4DJXVlhNkCe0fmg4Mb2INFUI0Joy04JrJbnB41dYKoaF3QZmlOZBpoJcoViWe1LrNOc60JqnKfYuDhzMqyMxFUc5pcoYJPOxCv7BpPyDDuzVoqMZMceLQlindTlRaXeiOKFrNNQTod-88xxozKs8qQz4NvFbEsEPjRYd-FkXo-nRfIou7HBKMgh2iN_Hd2Br1lTqV_GQwJwn8IvKFvG6jkkUx-XJt7eL_oDVztlpnMTd3q8dWPNpS0a5hLgBS5Px1O7CB3M36d-Ov5cm8QBsHAvx |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fT9swED-xMiFeYH8hwDZv2sNeojVxUtvSXiKgAi3r0DQ23iLHsaFSSavS8syH2CfcJ9ld6kagMQlpT4niS-LEPt_v7PPvAN4bTrx_lQyTVNswETYKFQ4JYc-UzilhhGvY-X_kYjCQZ2fqZAU-LffCLPgh2gk30oxmvCYFt5PK3dJyPRpR9h7KYr2aUBKZDqwefOuf5u1ILPwcC2IIrAuXnlmIInnam-_Yo0cXFA35N9S8i1wb09Pf_L9KP4ENDzlZtugjT2HF1s9g7YtfVH8OE-wqbHh7ZpD9zL5-PMyy_WN2PiceLJRjiG4ZokV22QbMsLFjF5TrczjDGjFdnw_HtrKX-vfNL3pmjJadTf32dSyu2HxCEwwv4LR_-H3_KPSJGEKToIkPSzRzslt147JndWQokR9HJ1w6ZYXVBHpSG6eGE9eLKEuFEK0rKy24VpIbPL6ETj2u7TYwozRPKpU4hWKVi6TWpeM60ZqXJY4vAXxYNkdhPEs5JcsYFUtvBf9g0fzBAN61opMFNce9QtimbTmRaR9leUHXyNkTady9jgLYWzZ54VX4qoh7EuEP-YsBvG2LUfloRUXXdjwnGYQ7xPATB7C16Crtq3hKcC4S-EVNj_h3HYssz5uTnYeLvoG1k4N-kR8PPu_Cekx7MpoY4j3ozKZz-woem-vZ8Gr62uvEHye_DJo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+international+WAO%2FEAACI+guideline+for+the+management+of+hereditary+angioedema-The+2021+revision+and+update&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Maurer%2C+Marcus&rft.au=Magerl%2C+Markus&rft.au=Betschel%2C+Stephen&rft.au=Aberer%2C+Werner&rft.date=2022-07-01&rft.issn=1398-9995&rft.eissn=1398-9995&rft.volume=77&rft.issue=7&rft.spage=1961&rft_id=info:doi/10.1111%2Fall.15214&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |